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SUMMARY
Heart development is the result of the tightly regulated spatio-temporally embryonic 
processes of lineage specification, tissue patterning, cellular proliferation, differentiation 
and morphogenesis that ultimately lead to the adult, fully functional heart. Congenital heart 
disease (CHD) occurs when normal cardiac development is impaired and the structure of 
the heart and great vessels is abnormal. It is very frequent and approximately nine people 
in 1000 are born with a congenital heart defect. A great research effort is under way to 
understand the molecular and genetic bases of CHD, as they can be manifested in the 
neonate but also in the adult individual. In this work, we have used a conditional loss-of-
function model of the Notch regulator Mib1, to show that Notch acting from the endocardium 
not only regulates early heart development, as it has been described previously, but also 
plays a crucial later role in the maturation of the cardiac valves and chambers. In the OFT 
valves, Notch regulates in a non-cell autonomous manner BMP signalling, repressing Bmp6 
and cellular proliferation in the valvular mesenchyme, allowing the valves to undergo the 
morphogenetic processes required for their maturation. In the ventricles, Notch activity 
in the endocardium activated from the myocardium sends maturation signals to the 
myocardium, so that compact and trabecular myocardium are established by the expression 
of trabecular markers (Anf, Bmp10 or Cx40) and compact zone markers (Hey2, N-myc or 
Tbx20), allowing ventricular compaction, and thus the formation of the adult contractile wall 
of the heart. Absence of these Notch-dependent signals produces LVNC in humans, the 
third most important cardiomyopathy, with a very poorly understood etiology, characterized 
by prominent and excessive trabeculations, with deep recesses in the ventricular wall. 
LVNC manifests as depressed systolic function. Classical complications include sys temic 
embolism, malignant arrhythmias, heart failure and sudden death. The importance of 
NOTCH in heart development and its impact in cardiomyopathies such as LVNC, opens a 
new research avenue into the identification of novel diagnostic and eventually, therapeutic 
targets. 

INTRODUCTION
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In this PhD thesis we have studied the 
role of the Notch signalling pathway in heart 
development, paying particular attention to 
two structures that are important substrates of 
CHD, the valves of the outflow tract (OFT) and 
the ventricles, that are essential components 
of the pumping machinery of the adult heart: 
the valves allow the flow of the blood from 
one cardiac chamber to another and prevent 
retrograde flow, the ventricles are the muscular 
wall that in the case of the left ventricle has 
to send the oxygenated blood to the rest of 
the body through the aortic valve. Failure to 
properly develop valves or ventricles causes 
CHD that severely compromises the life of the 
neonate and may cause its death if not treated 
on due time. 
Heart development
Development of the heart starts at 
embryonic day 7 in the mouse (E7) when 
pre-cardiac precursor cells move forward 
bilaterally into the lateral plate mesoderm to 
form the cardiac crescent (Fig. 1 A) (Harvey, 
2002). By E8, folding of the mesodermal layers 
from both sides of the embryo results in the 
formation of the linear heart tube that is not 
yet compartmentalised. The two mains tissues 
of the heart are present, the endocardium in 
the inside and the myocardium in the outside. 
The cells forming the original heart tube come 
from the first heart field (FHF), that will give 
rise later to part of the atria, left ventricle and 
atrio-ventricular canal (AVC) (Buckingham et 
al., 2005) (Fig. 1 A, B).
At E9.0, the heart starts to bend rightwards 
to relocate the tube in a manner that the future 
atria of the heart are located posterior to 
the common ventricle, this process is called 
cardiac looping. At the same time, it expands 
by the addition of cells from the second heart 
field (SHF) (Kelly and Buckingham, 2002). 
In the arterial pole of the heart, the SHF will 
contribute to the OFT, the right ventricle and 
the ventricular septum (Zaffran et al., 2004), 
whereas in the venous pole of the heart, the 
SHF contributes to atria and atrial septum 
(Snarr et al., 2008) (Fig. 1 A, B).
The heart divides afterwards into 
developmental domains that would allow the 
formation of two regions, the valvular and the 
chamber regions (Moorman and Christoffels, 
2003, Moorman et al., 2007, Aanhaanen et 
al., 2011) (Fig.1 B). Cardiac valve formation 
is restricted to AVC and OFT. It is in these 
two regions where the endocardial cushions, 
the primitive valves, are formed. Endocardial 
cells undergo an epithelial-to-mesenchyme 
transition (EMT) and populate the cardiac jelly 
that separates endocardium and myocardium. 
In the endocardium Notch is essential for the 
activation of EMT (Timmerman et al., 2004, 
Luna-Zurita et al., 2010). The transcription 
factors Snail1 (Timmerman et al., 2004, 
Luna-Zurita et al., 2010) and Snail2 (Niessen 
et al., 2008) are required for this process 
downstream of Notch, as they repress vascular 
endothelial cadherin (VE-C or Cdh5) so that 
the endocardial cells are capable of undergo 
EMT and invade the cardiac jelly (Timmerman 
et al., 2004). A complex signalling network that 
integrates different pathways such as Bmp, 
Tgf-b and Notch regulates the EMT process 
(Luna-Zurita et al., 2010, de la Pompa and 
Epstein, 2012). There are four cushions formed 
in the AVC and four in the OFT (Fig. 1B). By 
E10.5 the endocardial cushions are formed 
and the morphogenesis and maturation of the 
valves begins.
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At around the same time (E9.5), the 
process of trabeculation begins in the primitive 
ventricles. Trabeculae are highly organized 
sheets of cardiomyocytes that protrude 
towards the light of the ventricles (Ben-
Shachar et al., 1985). Trabeculae are the first 
structure that differentiates the ventricles in 
the developing heart (Sedmera et al., 1997). 
They increase the ventricular surface and 
allow the myocardium to grow in the absence 
of coronary vessels that will be formed 
later. They are important for contractibility, 
formation of the conduction system and 
blood flow direction in the ventricle. Although 
trabeculae start to form first in the left ventricle 
and then later in the right ventricle, there are 
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no differences between these structures in 
the two ventricles. Formed trabeculae have 
no free ends and they make the ventricle look 
like a sponge (Sedmera et al., 2000) (Fig.1 B). 
The Notch signalling pathway is essential for 
early trabeculation (Grego-Bessa et al., 2007).
From E10.5 onwards, the ventricular 
myocardium has two well-defined regions, 
morphologically and molecularly, the outer 
compact myocardium and the inner trabecular 
layer. The compact myocardium is less 
differentiated and shows a higher proliferation 
rate, than the trabecular myocardium 
more differentiated (Sedmera et al., 2000). 
Differentiated cardiomyocytes will give rise to 
the working myocardium and the conduction 
system (Sedmera et al., 2000). After ventricular 
septation is complete, around E13.5-E14.5, 
trabeculae are mature and they have to be 
remodel to continue ventricular development 
(Fig. 1 C).
When endocardial cushions and trabeculae 
are formed, a second phase in heart 
development begins. The structures that have 
risen during this first part of development have 
to mature in order to form a fully functional 
heart. AVC and OFT are septated, endocardial 
cushions are fused and finally they will be 
sculpted to form the mature leaflets of the 
heart. Simultaneously, the ventricular walls are 
compacted when the trabeculae become part 
of the ventricular wall. Little is known about 
the molecular networks that guide cardiac 
maturation, one aim of this PhD thesis has 
been to gain some knowledge about these 
later stages of heart development (Fig. 1 C).
Cardiac valve morphogenesis 
and maturation
The morphogenetic events that transform 
the endocardial cushions into mature valves 
are related to the septation of the heart and 
the separation of pulmonary and systemic 
blood circuitries. The correct maturation of 
the endocardial cushions is crucial for later 
function of the heart, and the consequences 
of defective morphogenesis of the leaflets at 
this stages will be observed later in the form 
of congenital heart disease (CHD), such as 
bicuspid aortic valve (BAV) (Srivastava, 2006).
After EMT has taken place, four endocardial 
cushions are formed in the AVC and in the 
OFT. Two mayor leaflets and two smaller 
lateral ones (Fig.1 B) (Wessels and Sedmera, 
2003). The mayor leaflets of the AVC form 
a fused bulk of mesenchyme that occupies 
Figure 1. Overview of early heart development. 
(A) Ventral views of the developing mouse embryo. At E7.0, cardiac progenitors (red) migrate to the 
center of the embryo to form the cardiac tube and at E7.5, two cardiac fields can be distinguished: the 
first heart field (FHF; red) and the second heart field (SHF; blue). By E8.0, the cardiac tube is formed 
where endocardium and myocardium are already present. At E9.0, the tube loops and the different 
cardiac regions become apparent. (B) Ventral view of the E9.5 heart, which consists of four anatomically 
distinct regions: atrium, atrioventricular canal (AVC), ventricle (V) and outflow tract (OFT). Endocardial 
cushions are formed in valvulogenic regions of the heart (green, OFT and blue, AVC) and trabeculae 
appear in the ventricles. (C) Longitudinal section depicting the heart. Once valve primordia (OFT, green 
and AVC, blue) and trabeculae are formed, the heart needs to mature and these structure undergo 
morphogenesis.
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the lumen of the AVC and it is required for 
the ventricular septation that will divide the 
systemic and pulmonary flows. The lateral 
leaflets do not fuse and will not be part of the 
atrio-ventricular (AV) complex, instead they 
will give rise to the mural leaflets of the mitral 
valve (Snarr et al., 2008). Something similar 
happens in the OFT, the major cushions fuse 
to form the aortic-pulmonary (AP) septum, 
while the intercalating cushions do not fuse 
and contribute only to the definitive leaflets. 
The endocardial cushions are not only 
formed by EMT-derived mesenchymal cells, 
there are other lineages that contribute to 
the cushions and drive its maturation. Thus, 
by E11.5 the OFT mesenchyme derived 
from the endocardium by EMT is invaded 
by mesenchyme cells that migrate rostro-
caudally from the neural crest. They form 
two prongs of mesenchyme in both sides 
of the future AP septum (de Lange et al., 
2004). Although neural crest cells make little 
contribution to the mature valves, they can 
still be observed in the adult valves (Jiang et 
al., 2000). There is an important cross-talk 
between the two populations of mesenchymal 
cells, endocardial- and neural crest- derived in 
the cushions, crucial for the maturation of the 
leaflets. Neural crest-derived, mesenchymal 
cells induce cell death in the mesenchyme, 
which is crucial for the delamination and 
sculpting of the leaflets (Jain et al., 2011, de 
la Pompa and Epstein, 2012). The neural 
crest does not contribute to the formation of 
the AV valves (Wessels et al., 2012). At E12.0, 
epicardial derived cells migrate through the 
AV junction into the endocardial cushions 
of the AVC. The contribution of these cells 
to the mature AV valves is mainly to the 
lateral cushions and only a few cells can be 
observed in the major AV cushions, but during 
development they will populate most of the 
leaflet (Wessels et al., 2012). After the invasion 
of the other lineages, the expansion of the 
cushions via cellular proliferation is driven 
by different signals such as Bmp (Eisenberg 
and Markwald, 1995), Wnt (Alfieri et al., 
2010) or Egf (Iwamoto et al., 2003). Two Bmp 
molecules, Bmp6 and Bmp7, are expressed 
in the OFT and required for cushion formation 
in the OFT. The double mutant Bmp6;Bmp7 
shows a marked delay and hypoplasia of the 
OFT cushions (Kim et al., 2001).
The last phases of valve development 
are characterized by the differentiation of 
the mesenchyme that has grown from EMT 
and invasion of the other lineages (Fig. 2). 
This forms a highly organized and stratified 
structure guided by the extracellular matrix. 
The exact mechanism that underlies these 
structural changes is unclear (de Vlaming 
et al., 2012). The elongation of the leaflets 
occurs between E15.5 and E18.5 and is 
due to an increase of cellular density and a 
reorganization of the extracellular matrix 
(Kruithof et al., 2007). Periostin that binds to 
collagen fibers modulates the diameter and the 
assembly of the fibers promoting fibrillogenesis 
by cross-linking (Norris et al., 2009). The 
reorganization of the matrix is regulated by 
Periostin and the coordinated actions of zinc 
metallopreoteases, ie: ADAMTS1 that cleaves 
versican and facilitates the dense packing 
of the mesenchyme, the sculpting of valves 
(Kern et al., 2006), and the differentiation of 
endocardial-, epicardial- and neural crest- 
derived mesenchyme will give rise to mature 
valves.
The leaflets of the AV valves will be attached 
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to the base of the ventricular walls by tendon-
like cords tendinae, the supporting apparatus 
of the valves, via the papillary muscles (Guy 
and Hill, 2012) that are formed by coalescence 
of trabeculae in the ventricles (Sedmera et 
al., 2000) (Fig. 2 A) while the OFT are self-
supporting and attach to the arterial wall (Fig. 
2 B). 
Finally, in mature valves the remodelled 
extracellular matrix is aligned to the blood 
flow. This suggests that there is a role for 
hemodynamic forces in the maturation of 
the valves that should be taken into account 
(Combs and Yutzey, 2009). Interestingly, 
endocardial expression of the active 
Notch1 receptor is restricted to the flow 
side of the valves (Del Monte et al., 2007), 
suggesting that there is an endothelial 
response to shear stress produced by the 
hemodynamic forces (Combs and Yutzey, 
2009) (Fig. 2).  
Failure of cardiac cushion remodelling 
giving rise to dysmorphic valves is a 
characteristic of some CHD such as tetralogy 
of Fallot in which, a dysmorphic pulmonary 
Figure 2. Valve maturation.
(A) Morphogenesis of the AVC valves. From E13.5 onwards the leaflets and tensile apparatus (dark 
red) of the AVC valves form predominantly by delamination of the inner layers of the inlet zone from the 
ventricular septal wall. The chordae tendinae that will form the supporting apparatus develop at this time. 
These structures and the leaflet itself are derived from the endocardium. (B) Morphogenesis of the OFT 
valves. The excavation of the cusps takes place by an initial solid ingrowth of the endothelium at the 
arterial face of the cusp, and subsequent lumenation. Elongation and remodeling of the primordia into 
mature valve structures is associated with regionalized cell proliferation and matrix alignment guided by 
hemodynamic forces. Myocardium is depicted in dark red, proteoglycans in blue and mesenchyme in 
gray.
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valve is accompanied by an overriding aorta 
(Greenway et al., 2009, Jain et al., 2011).
Ventricular maturation and 
trabecular compaction
After completion of ventricular septation 
around E14.5, further growth and maturation of 
the ventricular chambers requires a complete 
trabecular remodelling and reorganization into 
an apico-basal orientation that determines 
the shape of the ventricles. Trabeculae 
become compacted and as a result, there is 
a significant change in the ratio of compact 
vs. trabecular myocardium in the ventricle. 
Some of the trabeculae coalesce to produce 
part of the papillary muscles of the AV valves 
(Sedmera et al., 2000). 
Trabeculae compaction is accompanied 
by the hypoxia-dependent invasion of the 
coronary vasculature from the epicardium into 
the compact layer of the myocardium (Tao et 
al., 2013). As they compact, the intertrabecular 
recesses are transformed into capillaries of 
the rising coronary plexus. This is followed by 
a reorganization of the muscle fibres of the 
heart that organize in a three-layered spiral 
around the heart reflecting the twisting pattern 
of heart contraction (Sedmera et al., 2000).
Trabeculae stop proliferating while the 
proliferation of the compact zone sustains the 
growth of the chamber and the contribution 
of the compact layer to the heart becomes 
more significant than the one of the luminal 
trabeculations that will eventually disappear. 
How exactly this happens and what molecular 
mechanisms drive this process is unknown.
Left ventricular non-
compaction (LVNC)
LVNC is a cardiomyopathy of poorly 
understood etiology that is characterized by 
prominent and excessive trabeculations with 
deep recesses in the ventricular wall (Jenni et 
al., 2007) (Fig.3). It is caused by the intrauterine 
arrest of myocardial morphogenesis that leads 
to the presence of persistent trabeculae (Ritter 
et al., 1997). 
LVNC was first diagnosed in 1984, 
in a 33-year old woman assessed  by 
echocardiography (Engberding and Bender, 
1984). Since then, the heterogeneity of its 
symptoms might have left many LVNC cases 
undiagnosed (Jenni et al., 2007), giving 
a lower estimation of its real impact as a 
cardiomyopathy. The improvement in imaging 
technologies and the advent of CMRI, allows 
now a better diagnose of this disease and ten 
years after the first description, LVNC was 
included in the World Health Organization 
(WHO) catalogue of cardiomyopathies 
(Richardson et al., 1996). In 2006, the 
American Heart Association included LVNC to 
its list of genetic cardiomyopathies (Maron et 
al., 2006). 
 Although LVNC can manifest as depressed 
systolic function (Captur and Nihoyannopoulos, 
2010), its clinical manifestation and the age of 
the affected individual at symp tom onset are 
highly variable. Classical complications include 
sys temic embolism, malignant arrhythmias, 
heart failure and sudden death (Oechslin et 
al., 2000). LVNC is the third most common 
cardiomyopathy after dilated and hypertrophic 
cardiomyopathy, and its prevalence ranges 
from 0.05% to 0.3% of the general population 
(Ritter et al., 1997, Oechslin et al., 2000, 
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Stollberger and Finsterer, 2004).
Previously, it has been described that LVNC 
is caused by mutations in genes encoding 
mainly structural proteins of the muscle fibres 
(Klaassen et al., 2008), cytoskeletal (Ichida et 
al., 2001), nuclear-membrane (Hermida-Prieto 
et al., 2004) and chaperone proteins (Shou et 
al., 1998). With the excep tion of infantile cases 
in which the disease is ligated to chromosome 
X (Bione et al., 1996), familial forms of LVNC 
are transmitted as an autosomal-dominant 
trait (Captur and Nihoyannopoulos, 2010). The 
underlying molecular mechanisms producing 
the structural abnormalities leading to LVNC 
are still unknown (Towbin, 2010, Finsterer, 
2009). 
The NOTCH signalling pathway
Notch is an evolutionary conserved 
signalling pathway that during embryonic 
development regulates cell-fate specification, 
differentiation and tissue patterning (Artavanis-
Tsakonas et al., 1999). In the adult organism, 
Notch maintains tissue homeostasis via the 
regulation of a variety of cellular processes 
(Billiard et al., 2011, Kim and Shivdasani, 
2011). In general, the cells in which the 
pathway is active maintain an undifferentiated 
state (Kimble and Crittenden, 2007). Notch 
functions between adjacent cells, it is a 
local signalling pathway whereby one cell 
expressing higher levels of ligand becomes 
the signalling cell and the neighbouring one 
becomes the receiving cell, although this is a 
generalization that cannot be made extensive 
to all Notch settings. 
Notch takes its name from the Drosophila 
mutants that show notches in their wing edge 
(Mohr, 1919) and the gene was initially cloned 
in Drosophila in 1985 (Wharton et al., 1985). In 
mammals there are four Notch genes, Notch1-
Notch4, which are expressed in different 
tissues and at different times during embryonic 
development and in the adult (Del Amo et al., 
1992, Weinmaster et al., 1992, Lardelli et al., 
1994, Uyttendaele et al., 1996) (Fig. 5). The 
Figure 3. Example of LVNC heart CMRI.
Presence of persistent trabeculae in an adult LVNC heart (arrowheads) characteristic of the diseased 
hearts. rv, right ventricle; lv, left ventricle; ra, right atria; la, left atria. Image courtesy of Dr L. J. Jimenez-
Borreguero.
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Notch genes encode a long transmembrane 
receptor that has two distinct domains, an 
extracellular domain (NECD) responsible 
for the interaction with the ligands and an 
intracellular domain (NICD) responsible for 
signal transduction. 
The NECD contains tandem arrays of 
Epidermal Growth Factor (EGF)-like repeats 
(Artavanis-Tsakonas and Muskavitch, 2010). 
The number of EGF-like repeats varies 
by species and receptor subtype, ranging 
from 36 in Drosophila to as few as 11 in C. 
elegans (Artavanis-Tsakonas and Muskavitch, 
2010). The EGF repeats are implicated in the 
interaction with the ligand (Fehon et al., 1990, 
Rebay et al., 1991), three Lin/Notch repeats 
and the heterodimerization domain, which is in 
contact with the NICD. The NICD is composed 
of the RAM23 domain and 6 ankyrin repetitions 
responsible for the interaction with RBPJK, 
the transcriptional effector of the pathway; 
two nuclear localization signals (NLS), a 
transcriptional activation domain only present 
in Notch1 and Notch2, and a terminal PEST 
domain, that negatively regulates the stability 
of the receptor (Rechsteiner, 1988, Kopan, 
2002). The NECD and NICD are synthetized as 
a single polypeptide, which is directly cleaved 
after translation by a Furin-convertase in the 
Golgi. This first (S1) cleavage (Blaumueller et 
al., 1997, Logeat et al., 1998) is necessary to 
form the functional heterodimeric receptor that 
will be translocated to the membrane where 
the two domains are still associated by Ca2+-
dependent non-covalent bonds (Rand et al., 
2000). 
There are two families of ligands that are 
expressed in the signalling cell, Delta-like (Dll) 
and Jagged (Jag). In mammals there are three 
Delta-like genes, Delta-like 1 (Bettenhausen et 
al., 1995), Delta-like 3 (Dunwoodie et al., 1997) 
and Delta-like 4 (Shutter et al., 2000), and two 
Jagged, Jagged1 (Lindsell et al., 1995) and 
Jagged2 (Shawber et al., 1996) (Fig. 5). The 
mammalian Notch ligands are homologues 
to Delta and Serrate from Drosophila. The 
ligands are type I transmembrane proteins 
and their extracellular domains are composed 
by a variable number of EGF-like domains 
responsible for the interaction with the receptor 
and the DSL (Delta, Serrate, Lin12) domain 
(Fig. 4, yellow) (Kopan, 2002). The EGF-like 
repetitions are continuous in the case of Delta 
while in Jagged they are interspersed by a 
short linker sequence. The Jagged ligands 
also have a cysteine-enriched domain (Kopan, 
2002).
The glycosil transferase Fringe can modify 
the EGF-like domain in the NECD of the receptor 
by adding O-fucose glycans (Blair, 2000) (Fig. 
5). This modification determines which ligand 
preferentially binds to the receptor. Delta 
ligands bind to the Fringe-modified receptors 
and, on the contrary, Jagged ligands bind to 
the not modified Notch receptors (Panin et al., 
1997). Fringe introduces an additional level of 
regulation in the Notch pathway by selecting 
which ligand is able to activate Notch. There is 
evidence that the presence of Fringe shifts the 
activation balance towards Delta-like ligands 
at the expense of Jagged ligands when both 
molecules are expressed at the same time in 
the same tissue (Benedito et al., 2009, Golson 
et al., 2009). 
Mind bomb
There are two families of E3 ubiquitin ligases 
that regulate the endocytosis of the Notch 
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ligands when bound to NECD, a prerequisite 
for Notch activation. These E3 ubiquitin 
ligases are Neuralized (Neurl) (Deblandre et 
al., 2001) and Mind bomb (Mib) (Itoh et al., 
2003). Although there are two members of the 
Neurl family in mammals they are dispensable 
during embryonic development and mice 
with targeted mutations in either Neurl genes 
do not show any phenotypic alteration and 
are viable (Vollrath et al., 2001, Ruan et al., 
2001, Koo et al., 2007). In the case of the Mib 
family, there are two members Mib1 (Itoh et 
al., 2003) and Mib2 (Koo et al., 2005b). Only 
Mib1 is required for development (Koo et al., 
2007) although Mib2 is highly expressed in 
adult tissue (Koo et al., 2005b). Mib1 binds 
specifically to the two families of Notch 
ligands, Delta-like (Chen and Casey Corliss, 
2004, Itoh et al., 2003) and Jagged (Hansson 
et al., 2010, Koo et al., 2007), and it is a point 
of regulation of the pathway in the signalling 
cell. The 110kDa protein encoded by the 
Mib1 gene contains five domains, two Mib-
Herc2 domains separated by one ZZ Zinc 
finger domain, followed by two Mib domains 
responsible for the interaction with the ligand, 
eight ankyrin repeats that fold the protein 
together, and towards the C-terminus and 
spaced by a coiled-coil domain, three RING 
fingers responsible for the enzymatic activity 
of the pathway (Barsi et al., 2005) (Fig. 4). 
Mib1 is expressed ubiquitously throughout 
the developing embryo (Barsi et al., 2005). 
Various studies have shown the importance 
of Mib1 during development and that targeted 
inactivation of Mib1 in mice produces Notch 
loss of function-like phenotypes (Koo et al., 
2007). Thus, MIb1 is required for vascular 
development and its inactivation leads to 
a Dll4-like phenotype, skin epithelial cells 
differentiation and cerebellum development, 
its inactivation producing a Jag1-like 
phenotype or in the ectordermal ridge where 
the deletion of Mib1 produces a Jag2-like 
phenotype (Koo et al., 2007). Mib1 is also 
required for development of the collecting 
tubes of the kidney (Jeong et al., 2009), 
pancreatic b-cell formation (Horn et al., 2012), 
T-cell development (Shah et al., 2012, Jeong 
et al., 2012), gastrointestinal secretory cell 
maturation (Capoccia et al., 2013) and in the 
control of neurogenesis and gliogenesis in the 
spinal cord (Kang et al., 2013).
The importance of Mib1 during 
development and the fact that the two families 
Figure 4. Structure of Mib1 protein.
Schematic representation of Mib1 domains. Two Mib-Herc2 domains  (green) separated by one ZZ 
Zinc finger (olive green) followed by two Mib domains (dark green) responsible for the interaction with the 
ligand. Eight ankyrin repeats (blue) that fold the protein together and towards the C-terminus three RING 
fingers (orange) with a Coiled coil domain (red) in between them responsible for the enzymatic activity of 
the pathway. Modified from (Barsi et al., 2005)
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of Notch ligands are its substrates, make this 
E3 ubiquitin ligase a powerful tool to study 
the role of Notch in development. Mib1 is 
ubiquitously expressed and thus is essential 
for Notch signalling activation as it regulates 
all the input from the Notch ligands so that 
Mib1 deletion would allow us to explore the 
total loss of function of the Notch pathway. 
Thus, tissue-specific inactivation of Mib1 will 
give us insights in the importance of the origin 
of Notch signalling and the particular role of 
the different ligands in the heart. 
NOTCH activation
Upon interaction of ligand and receptor, 
Mib1 targets by ubiquitylation the ligand to 
endocytosis (Itoh et al., 2003). The ligands 
are endocytosed, mechanically pulling NECD 
producing a conformational change that 
liberates the S2 cleavage site (Parks et al., 
2000) (Fig. 5). The liberation of the S2 site 
allows a metalloprotease of the ADAM family 
to cleave the NECD (Hartmann et al., 2002) 
that is finally endocytosed into the signalling 
cell together with the ligand. Immediately 
after, g-secretase/Presenilin cleaves the 
receptor in the S3 site, liberating the NICD 
in the cytoplasm of the receiving cell (Okochi 
et al., 2002) (Fig. 5). Due the NLS, the NICD 
translocates to the nucleus where it binds to 
the transcription factor CSL or RBPJK via by 
the RAM23 domain (Tamura et al., 1995).
In the absence of Notch signalling 
activation, RBPJK is bound to transcriptional 
repressors as Mint (Tanigaki and Honjo, 2007) 
or SMRT (Silencing mediator of retinoic and 
thyroid hormone receptors) (Mumm and 
Kopan, 2000) that inhibit gene expression. 
Upon the interaction of NICD with RBPJK 
the transcriptional repressors are released 
and transcriptional activators such as Master 
mind (Maml) (Wu et al., 2000) are recruited, 
forming a protein complex that activates the 
expression of the target genes of the pathway 
(Fig. 5).  
The most studied target genes of the 
pathway in cardiac development are the basic-
helix-loop-helix (bHLH) repressor transcription 
factors of the Hes (Hairy and enhancer of 
split) and Hey (HESR) (Hairy and enhancer 
of split repressor) (Kokubo et al., 1999, Iso 
et al., 2001, Iso et al., 2003) (Fig. 5). The 
spectrum of immediate targets is large and 
include those encoding the oncogene c-myc, 
another bHLH protein that enhances cellular 
growth in leukaemia (Palomero et al., 2006, 
Weng et al., 2006), the cell cycle regulator 
p21 (Devgan et al., 2005, Rangarajan et al., 
2001) or the repressor transcription factor 
Snail1 (Timmerman et al., 2004, Sahlgren 
et al., 2008) required for EMT and valvular 
development (Fig. 5). The Notch negative 
regulator NRARP (Notch regulated ankyrin 
repeat protein) (Krebs et al., 2001, Lamar et 
al., 2001) is also a direct target gene of the 
pathway (Fig. 5). 
NOTCH and cardiac 
development
Notch is implicated in several processes 
during the development of the heart (Rones et 
al., 2000, Nemir et al., 2006, High and Epstein, 
2008, de la Pompa and Epstein, 2012). 
In the mid-gestation mouse embryo, Notch1 
is active (implying that N1ICD can be detected) 
throughout the endocardium of the AVC and 
OFT, where the valves will form (Del Monte et 
al., 2007). During valve primordium formation, 
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Notch activates the expression of Snail1 that 
represses Vascular Endothelial Cadherin (VE-
C or Cdh5), allowing endocardial cells in the 
AVC and OFT to undergo EMT and invade 
the cardiac jelly in between endocardium and 
myocardium to form the endocardial cushions, 
the valve primordia (Timmerman et al., 2004). 
Hey1 and Hey2 restrict Bmp2 expression to 
the AVC and OFT restricting valve formation 
to non-chamber territorires (Rutenberg et 
al., 2006, Kokubo et al., 2004). Although 
Notch is not responsible for the expression of 
Hey genes in the myocardium (Timmerman 
et al., 2004) the overexpression of the 
N1ICD in the myocardium is accompanied 
by ectopic expression of Hey1, disrupting 
AVC development (Watanabe et al., 2006, 
Luna-Zurita et al., 2010). The double mutant 
Hey1;Hey2 is not able to produce endocardial 
cushions and EMT is totally blocked (Kokubo 
et al., 2005). 
At E9.5, Notch1 is expressed throughout 
Figure 5. Notch signalling pathway.
The Notch ligands Delta and Jagged are expressed in the membrane of the signalling cell and are 
characterized by the DSL motif (yellow) located in the extracellular domain. Notch receptors are processed 
in the Golgi apparatus, S1-cleavaged by Furin, and sugar-modified by Fringe to form the functional 
heterodimer that is located in the membrane of the receiving cell. Upon ligand-receptor interaction two 
cleavage events, S2 by an ADAM protease and S3 by γ-secretase/Presenilin, liberate N1ICD in the 
cytoplasm of the receiving cell. NICD translocates to the nucleus and together with MAML, forms an 
transcriptional activation complex with RBPJK that activates the transcription of the target genes of the 
pathway including Hes, Hey, p21 etc.
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the endocardium of the developing ventricles, 
but it is only active at the base of the trabeculae 
(Del Monte et al., 2007), where it signals to 
the myocardium to induce its proliferation and 
differentiation and form the trabeculae (Grego-
Bessa et al., 2007). Analysis of standard 
and endothelial-specific Notch1 and RBPJk 
mutants shows that trabeculation is severely 
impaired and only primitive, poorly organized 
trabeculae can be observed in these mutants 
(Grego-Bessa et al., 2007). Molecular 
analysis indicates that during trabeculation 
Notch modulates three different signals: 
EphrinB2 (Adams et al., 1999), expressed 
in the endocardium is a direct Notch target 
(Grego-Bessa et al., 2007). Nrg1 (Hertig et 
al., 1999) also expressed in the endocardium, 
is an indirect Notch target and its expression 
depends both of Notch and EphrinB2 (Grego-
Bessa et al., 2007). Nrg1 induces the formation 
of the ventricular conduction system, a feature 
of ventricular maturation (Rentschler et al., 
2002). A third signalling pathway is Bmp10 
(Chen et al., 2004), expressed in trabecular 
myocardium and whose expression is 
severely down-regulated in Notch pathway 
mutants, suggesting that Notch is required to 
produce a signal that activates Bmp10 in the 
myocardium (Grego-Bessa et al., 2007).
Notch is also active in the proepicardium 
and later in the epicardium during the 
formation of epicardial derivatives. Epicardial 
Notch modulates cell differentiation in the 
proepicardium organ and later it is required for 
the arterial commitment and coronary vessel 
formation that will sustain myocardial growth 
during ventricular maturation (del Monte et al., 
2011, Grieskamp et al., 2011).
INTRODUCCIÓN
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En este trabajo hemos estudiado el 
papel de la vía de señalización Notch en el 
desarrollo del corazón, prestando especial 
atención a dos estructuras por su relación 
con CHD, las válvulas del tracto de salida 
(OFT) y los ventrículos, que son esenciales 
para función cardíaca. Las válvulas permiten 
que el flujo sanguíneo avance de manera 
unidireccional por el corazón y evitan el reflujo. 
Los ventrículos son la pared muscular, que en 
caso del ventrículo izquierdo se encarga de 
bombear sangre oxigenada por el resto del 
cuerpo a través de la válvula aortica. Errores 
durante los procesos de desarrollo de las 
válvulas o los ventrículos causan CHD, que 
compromete la vida de los recién nacidos y 
pueden causar su muerte si no son tratadas 
a tiempo.
Desarrollo del corazón
El desarrollo cardíaco comienza en el día 
de desarrollo embrionario 7.0 en ratón (E7), 
cuando los precursores cardiacos migran 
bilateralmente hacia delante al interior del 
mesodermo lateral, donde forman la media 
luna cardiaca (Harvey, 2002). A E8.0, la 
fusión de las capas mesodérmicas de ambos 
lados, produce un tubo linear que todavía no 
está compartimentalizado. Los dos tejidos 
principales del corazón, el endocardio en el 
interior y el miocardio en el exterior, ya están 
presentes en el tubo cardiaco. Las células que 
forman el tubo cardiaco original provienen del 
campo cardiaco primario (FHF), el cuál dará 
lugar a parte de las aurículas, el ventrículo 
izquierdo y el canal atrio ventricular (AVC) 
(Buckingham et al., 2005) (Fig. 1 A, B).
A día E9.0, comienza el proceso de torsión 
cardíaca durante el cual el tubo cardíaco gira 
hacia la derecha, de manera que las futuras 
aurículas se sitúan en una posición posterior 
al ventrículo común. Simultáneamente, el 
tubo se expande por la adición del células 
del campo cardiaco secundario (SHF) (Kelly 
and Buckingham, 2002). En el polo arterial 
del corazón, el SHF contribuye al OFT, 
al ventrículo derecho y a parte del septo 
interventricular (Zaffran et al., 2004); por otro 
lado, en el polo venoso del corazón el SHF 
contribuye a parte de las aurículas y al septo 
arterial (Snarr et al., 2008) (Fig.1 A, B). 
Inmediatamente después pueden 
distinguirse dos territorios en los que se 
desarrollarán las válvulas cardíacas y los 
ventrículos (Moorman and Christoffels, 2003, 
Moorman et al., 2007, Aanhaanen et al., 2011) 
(Fig. 1 B). Los territorios donde se formarán 
las válvulas del corazón son el AVC y el OFT. 
Inicialmente, a E9.5 en el AVC y E10.5 en 
el OFT, las células del endocardio sufren un 
proceso de transición epitelio-mesénquima 
(EMT) e invaden la gelatina cardiaca que 
separa el endocardio y el miocardio. En el 
endocardio, Notch juega un papel crucial en 
la activación de la EMT mediante la activación 
directa de los factores de transcripción Snail1 
(Timmerman et al., 2004, Luna-Zurita et al., 
2010) y Snail2 (Niessen et al., 2008) que 
reprimen la cadherina del endotelio vascular 
(VE-C o Cdh5), permitiendo que las células 
del endocardio se despeguen unas de otras, 
adquieran un fenotipo mesenquimal e invadan 
la gelatina cardiaca. Una compleja red de 
señalización que integra diferentes vías de 
señalización como Bmp, Tgf-b y Notch regula 
la EMT (Luna-Zurita et al., 2010, de la Pompa 
and Epstein, 2012). En el AVC se forman 
cuatro colchones endocárdicos, al igual que 
en el OFT. Posteriormente, tienen lugar  los 
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procesos de morfogénesis y maduración 
valvular. 
Igualmente a E9.5, comienza la 
trabeculación ventricular. Las trabéculas son 
crestas de cardiomiocitos que crecen hacía la 
luz del ventrículo (Ben-Shachar et al., 1985). 
Las trabéculas son las primeras estructuras 
que se diferencian en los ventrículos (Sedmera 
et al., 1997). Incrementan la superficie 
ventricular y permiten que el miocardio se 
desarrolle en ausencia de los vasos coronarios 
que se formarán más adelante.  A pesar de 
que las trabéculas comienzan a desarrollarse 
primero en el ventrículo izquierdo y después 
en el derecho, no hay diferencias estructurales 
entre ambos. Una vez que se forman las 
trabéculas, no tienen el limite superior libre 
sino que se unen, de manera que el interior 
del ventrículo parece una esponja (Sedmera 
et al., 2000) (Fig. 1 B). La vía de señalización 
Notch es crucial para la formación de las 
trabéculas y las maduración de los ventrículos 
(Grego-Bessa et al., 2007). 
A E10.5, en los ventriculos puede 
distinguirse la zona compacta, situada hacia 
la parte exterior y que contiene cardiomiocitos 
inmaduros con una elevada proliferación, e 
internamente,  la zona trabecular ocupada por 
las trabéculas que contiene cardiomiocitos 
en diferenciación con una baja proliferación 
(Sedmera et al., 2000). Estos cardiomiocitos 
se diferenciarán tanto en cardiomiocitos 
contráctiles como en células del sistema de 
conducción (Sedmera et al., 2000).
A E13.5-E14.5, se completa la septación 
interventricular y la pared del ventrículo se 
compacta y las trabéculas pasan a formar 
parte de la pared ventricular (Fig. 1 B). 
Igualmente, después de la septación del AVC 
y OFT (Fig. 1 B), los colchones del endocardio 
se fusionan primero  y se transforman después 
en las valvas maduras de las válvulas. Los 
mecanismos moleculares que regulan estos 
procesos no se conocen bien. Uno de los 
objetivos de esta tesis doctoral ha sido el 
de contribuir a entender estos procesos del 
desarrollo cardíaco (Fig. 1 C).
Morfogénesis y maduración 
valvular
Los eventos morfogenéticos que 
transforman los colchones del endocardio 
en válvulas cardiacas maduras están 
relacionados con la septación del corazón y 
con la separación de los circuitos pulmonar 
y sistémico. La correcta maduración de los 
colchones es crucial para la función cardíaca 
y las consecuencias de los defectos en estos 
procesos puede manifestarse más tarde 
en forma de enfermedades congénitas del 
corazón (CHD) (Srivastava, 2006). 
La EMT resulta en la formación de cuatro 
colchones del endocardio en el AVC y cuatro en 
el OFT, en ambos casos dos principales y dos 
laterales (Wessels and Sedmera, 2003) (Fig. 
1 B). Los colchones principales del AVC se 
fusionan y forman una masa de mesénquima 
que ocupa el lumen del AVC y es necesario 
para la septación ventricular que va a dividir 
los flujos pulmonar y sistémico. Los colchones 
laterales no se fusionan y no forman parte del 
complejo atrio-ventricular (AV), directamente 
darán lugar a las valva mural de la válvula 
mitral. (Snarr et al., 2008). Algo similar ocurre 
en el OFT, donde los colchones principales 
se fusionan para formar el septo aórtico-
pulmonar (AP) y los colchones laterales no 
se fusionan y sólo forman parte de las valvas 
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definitivas. 
Los colchones del endocardio no sólo están 
formados por células que derivan de la EMT, 
otros linajes celulares invaden los colchones 
y contribuyen a la maduración de las válvulas. 
A E11.5, el mesénquima del OFT ha sido 
invadido por células mesenquimáticas que 
migran rostro-caudalmente desde la cresta 
neural formando dos olas a ambos lados 
del futuro septo AP (de Lange et al., 2004). 
Aunque la participación de las células de la 
cresta neural en el desarrollo de las válvulas 
es pequeña, estas células están presentes 
en las valvas maduras (Jiang et al., 2000). 
Sin embargo, la interacción entre ambas 
poblaciones de células en los colchones 
endocárdicos es esencial para la maduración 
de las válvulas. Las células derivadas de la 
cresta neural inducen muerte celular en el 
mesénquima del colchón,  necesaria  para la 
remodelación de las valvas (Jain et al., 2011, 
de la Pompa and Epstein, 2012). Estas células 
no participan en el desarrollo de las válvulas 
(Wessels et al., 2012). A E12.0, células 
derivadas del epicardio migran a través de 
la unión AV en los colchones endocárdicos 
del AVC. Estas células participarán sobre 
todo en los colchones laterales, donde 
durante el desarrollo terminarán poblando 
finalmente la mayoría de la valva, mientras 
que sólo algunas células formarán parte de 
las valvas de la válvula madura (Wessels 
et al., 2012). Después de la invasión de las 
células derivadas de la cresta neural y del 
epicardio la expansión de los colchones por 
medio de proliferación celular está regulada 
por diferentes señales como Bmp (Eisenberg 
and Markwald, 1995), Wnt (Alfieri et al., 2010) 
o Egf (Iwamoto et al., 2003). Dos moléculas 
de la vía de Bmp, Bmp6 y Bmp7, se expresan 
en el OFT y son necesarias para la formación 
de los colchones del endocardio en esta 
estructura. El doble mutante Bmp6;Bmp7 
muestra un marcado retraso en el desarrollo 
de los colchones endocárdicos en el OFT 
(Kim et al., 2001).
Las últimas fases del desarrollo de las 
válvulas está caracterizada por la diferenciación 
y morfogénesis del mesénquima valvular (Fig. 
2). Este proceso aún poco conocido, resulta 
en una estructura altamente organizada y 
estratificada guiada por la matriz extracelular 
(de Vlaming et al., 2012). La elongación de las 
valvas ocurre entre E15.5 y E18.5 mediante 
un incremento de la densidad celular y 
reorganización de la matriz extracelular 
(Kruithof et al., 2007). Periostina, que se une 
a las fibras de colágeno modula el diámetro de 
éstas y su interacción mediante cross-linking, 
lo que promueve la fibrilogénesis (Norris et 
al., 2009). La reorganización de la matriz está 
regulada por Periostina y la acción coordinada 
de metaloproteasas de Zinc como ADAMTS1 
que proteolizan Versican, esto facilita un denso 
empaquetamiento del mesénquima (Kern et 
al., 2006). Esto promueve la diferenciación 
de las células que derivan del endocardio, 
epicardio y cresta neural que darán lugar a las 
válvulas maduras. 
Las valvas del AVC están unidas a la base 
de la pared ventricular por cuerdas tendinosas 
parecidas a tendones a través de los músculos 
papilares (Guy and Hill, 2012), esto constituye 
el aparato de soporte de las válvulas. El 
aparato de soporte se forma por la unión de 
varias trabéculas  en el ventrículo (Sedmera 
et al., 2000). Sin embargo, las válvulas del 
OFT se mantienen sin soporte externo y se 
unen a la pared de la arteria (Fig. 2 A). 
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Finalmente, en las válvulas maduras 
la matriz extracelular está alineada con el 
flujo sanguíneo, lo que sugiere un papel 
de las fuerzas hemodinámicas durante la 
maduración de las válvulas (Combs and 
Yutzey, 2009). En este aspecto, es interesante 
resaltar que la expresión en el endocardio 
del receptor Notch1 se restringe al lado de 
las válvulas que se encuentra bajo el flujo 
sanguíneo (Del Monte et al., 2007), lo que 
sugiere una reacción al flujo sanguíneo por 
parte del endotelio valvular que resultaría en 
la activación mecánica de Notch (Combs and 
Yutzey, 2009) (Fig. 2).
La falta de remodelación de los colchones 
endocárdicos que da lugar a válvulas 
dismórficas es una característica de algunas 
CHD como la tetralogía de Fallot en la cuál la 
válvula pulmonar dismórfica está acompañada 
por el cabalgamiento de la aorta (Greenway et 
al., 2009, Jain et al., 2011). 
Maduración trabecular y 
compactación ventricular
Después de completarse la septación 
ventricular a E14.5, la continuación del 
crecimiento y maduración de los ventrículos 
requiere una completa remodelación y 
reorganización de las trabéculas que se 
orientan de manera apico-basal, lo que 
determinará la forma de los ventrículos. Las 
trabéculas se compactan, lo que cambia la 
relación entre miocardio compacto y miocardio 
trabecular en el ventrículo. Algunas de estas 
trabéculas se unirán para formar los músculos 
papilares de las válvulas AV (Sedmera et al., 
2000). 
La compactación de las trabéculas está 
acompañada por la invasión dependiente de 
hipoxia del miocardio compacto por parte de 
la vasculatura coronaria que provienen del 
epicardio (Tao et al., 2013). Simultáneamente 
a la compactación trabecular, los recesos 
intertrabeculares pasan a formar parte 
del emergente plexo coronario. Esto es 
seguido por una reorganización de las fibras 
musculares que se organizan en una espiral 
de tres capas alrededor del corazón. Esta 
espiral refleja el patrón de contracción del 
corazón (Sedmera et al., 2000). 
Las cardiomiocitos de las trabéculas no 
proliferan y el crecimiento del órgano lo 
mantiene la proliferación de los cardiomiocitos 
de la zona compacta del miocardio compacto. 
De esta manera cambia la relación del 
grosor entre  el miocardio trabecular y el 
compacto, y este último se transforma en 
el más prominente en el corazón, mientras 
que las trabéculas en el lumen del ventrículo 
terminarán por desaparecer. Este proceso y 
los mecanismos moleculares subyacentes, 
son muy poco conocidos.
Miocardiomiopatía no 
compactada del ventrículo 
izquierdo (LVNC)
LVNC es una miocardiopatía de cuya 
etiología se sabe muy poco y que está 
caracterizada por unas trabéculas prominentes 
y excesivamente grandes en la pared del 
ventrículo izquierdo  (Jenni et al., 2007) (Fig. 
3). Se ha sugerido que al menos en algunos 
casos, esta enfermedad se produce por 
un bloqueo intrauterino de la morfogénesis 
del miocardio que lleva a la presencia de 
trabéculas (Ritter et al., 1997). 
La primera vez que se diagnosticó la LVNC 
fue en 1984 en una mujer de 33 años de 
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edad mediante ecocardiografía (Engberding 
and Bender, 1984). Desde este primer caso, 
la heterogeneidad de los síntomas de la 
enfermedad puede haber hecho que muchos 
casos de LVNC no hayan sido diagnosticados 
(Jenni et al., 2007) y como consecuencia 
atribuirse a esta miocardiopatía una menor 
prevalencia de la que realmente tiene. El 
desarrollo de las herramientas diagnósticas 
(la incorporación de la RMN), han permitido un 
mejor y más preciso diagnostico, de manera 
que 10 años después del primer diagnóstico, 
la LVNC  se incluyó en la clasificación de 
miocardiopatía de la Organización Mundial 
de la Salud (WHO) como miocardiopatía “sin 
clasificar” (Richardson et al., 1996). En 2006 
la Asociación Americana del Corazón incluyó 
la LVNC en la lista de miocardiopatías de 
origen genético (Maron et al., 2006).
La LVNC se puede manifestar como una 
reducción de la función sistólica (Captur and 
Nihoyannopoulos, 2010), sin embargo su 
manifestación clínica y la edad con la que 
debutan los pacientes afectados es altamente 
variable. Las complicaciones clásicas que se 
observan en los pacientes de LVNC pueden 
ser embolias, arritmias, fallo cardiaco e 
incluso muerte súbita (Oechslin et al., 2000). 
La LVNC es la tercera miocardiopatía más 
común detrás de la miocardiopatía dilatada e 
hipertrófica y su prevalencia va desde 0.05% 
a 0.3% de la población general (Ritter et al., 
1997, Oechslin et al., 2000, Finsterer, 2009). 
Las mutaciones que se han asociado 
a la LVNC se han relacionado con genes 
que codifican proteínas estructurales de las 
fibras musculares; proteínas del sarcómero 
(Klaassen et al., 2008), citoesqueléticas 
(Ichida et al., 2001), de membrana nuclear 
(Hermida-Prieto et al., 2004) y chaperonas 
(Shou et al., 1998). Con la excepción de 
los casos pediátricos, en cuyo caso la 
enfermedad está ligada al cromosoma X 
(Bione et al., 1996), los casos familiares de 
LVNC son heredados de manera autosómica 
dominante. A pesar de la utilidad diagnóstica 
de estos estudios genéticos, los mecanismos 
moleculares cuya alteración da lugar a la 
LVNC son aún desconocidos.
La vía de señalización Notch
Notch es una vía de señalización 
conservada evolutivamente que está 
implicada en múltiples procesos durante el 
desarrollo, ya que regula la especificación de 
los  destinos celulares, la diferenciación celular 
y la formación de patrón tisular (Artavanis-
Tsakonas et al., 1999). En el organismo adulto 
Notch mantiene la homeostasis tisular (Billiard 
et al., 2011, Kim and Shivdasani, 2011). Las 
células en las cuales la vía está activa tienden 
a mantener un estado más indiferenciado 
(Kimble and Crittenden, 2007). Notch es una 
vía de señalización local, ya que implica a 
células que están en contacto. Aunque el 
patrón de expresión de los ligandos es muy 
complejo, podemos decir que la activación de 
la vía ocurre cuando una célula que expresa 
altos niveles de ligando (célula señalizadora) 
interactúa con una célula vecina que expresa 
el receptor Notch (célula  receptora).
Notch recibe su nombre de los mutantes 
de Drosophila que presentan unas muescas 
(Notch en inglés) en el borde del ala (Mohr, 
1919). El gen Notch fue inicialmente clonado 
en Drosophila en 1985 (Wharton et al., 
1985). En mamíferos hay cuatro receptores 
Notch, Notch1-Notch4, que se expresan 
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en diferentes tejidos en diferentes estadios 
durante el desarrollo y más tarde en la vida 
adulta (Del Amo et al., 1992, Weinmaster et 
al., 1992, Lardelli et al., 1994, Uyttendaele et 
al., 1996) (Fig. 5).  Los genes Notch codifican 
un gran receptor transmembrana que tiene 
dos dominios diferenciados, uno extracelular 
(NECD), responsable de la interacción 
con los ligandos y otro intracelular (NICD), 
responsable de la transducción de la señal. 
El NECD contiene varias repeticiones 
del dominio Epidermal Growth Factor (EGF) 
(Artavanis-Tsakonas and Muskavitch, 2010) 
implicados en la interacción con los ligandos 
(Fehon et al., 1990) (Rebay et al., 1991). El 
número de repeticiones del dominio EGF-
likevaría entre especies y receptor, va 
desde 36 en Drosophila hasta sólo 11 en C. 
elegans (Artavanis-Tsakonas and Muskavitch, 
2010). Tres repeticiones del dominio Lin/
Notch y un dominio de heterodimerización 
con el que se mantiene unido con el NICD. 
El NICD se compone del dominio RAM23 y 
seis repeticiones de Ankyrina responsables 
de la interacción con RBPJK, el efector 
transcripcional de la vía; dos señales de 
localización nuclear (NLS), un dominio de 
activación transcripcional que sólo está 
presente en Notch1 y Notch2, y un dominio 
terminal PEST que regula negativamente 
la estabilidad del receptor (Rechsteiner, 
1988, Kopan, 2002). El NECD y el NICD 
son sintetizados como un único polipéptido 
que después de la traducción, se procesa 
proteolíticamente en el Golgi por una Furin-
convertasa. Este corte S1 (Blaumueller et 
al., 1997, Logeat et al., 1998) es necesario 
para formar el receptor heterodimérico que 
se transloca a la membrana donde los dos 
dominios NICD y NECD están asociados 
mediante enlaces no covalentes de Ca2+ 
(Rand et al., 2000).
Hay dos familias de ligandos que se 
expresan en la célula señalizadora, Delta-
like (Dll) y Jagged (Jag). En mamíferos hay 
tres genes Delta, Delta-like 1 (Bettenhausen 
et al., 1995), Delta-like 3 (Dunwoodie et al., 
1997) y Delta-like 4 (Shutter et al., 2000), y 
dos Jagged, Jagged1 (Lindsell et al., 1995) y 
Jagged2 (Shawber et al., 1996) (Fig. 5). Estos 
ligandos de mamíferos son homólogos de 
Delta y Serrate de Drosophila. Los ligandos 
son proteínas transmembrana de tipo I cuyo 
dominio extracelular se compone de una 
repetición de dominios EGF responsables 
de la interacción con el receptor y el dominio 
DSL (Delta, Serrate, Lin12) (Fig. 5 amarillo). 
Los dominios EGF son continuos en el caso 
de Delta, mientras que en los ligandos de 
la familia Jagged, están separados por una 
pequeña secuencia espaciadora. Los ligandos 
Jagged además tienen un dominio rico en 
cisteínas (Kopan, 2002).
La glicosil-transferasa Fringe puede 
modificar los dominios repetidos de 
EGF en los receptores Notch añadiendo 
O-fucosa glicanos (Blair, 2000) (Fig. 5). Esta 
modificación de los azúcares en los dominios 
EGF de Notch determina con que ligando 
interactúa de manera preferente. Por ejemplo, 
los ligandos Delta se unen preferencialmente 
con receptores modificados por Fringe en 
detrimento de Jagged. En caso de que el 
receptor no esté modificado no hay diferencia 
entre la unión de uno u otro ligando (Panin 
et al., 1997). De esta manera, Fringe añade 
un nuevo nivel de regulación a la activación 
de Notch, regulando que ligando es capaz de 
activar la señalización por Notch. Esta función 
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es muy importante, ya que existen evidencias 
de que la presencia de Fringe cambia el 
equilibrio entre Jagged y Delta cuando se 
expresan en el mismo tejido (Benedito et al., 
2009, Golson et al., 2009). 
Mind bomb
Existen dos familias de E3 ubiquitina 
ligasas que regulan la endocitosis de los 
ligandos una vez que se ha unido al NECD, 
un requisito esencial para la activación 
de Notch. Estas ubiquitina ligasas son 
Neuralized (Neurl) (Deblandre et al., 2001) y 
Mind bomb (Mib) (Itoh et al., 2003). Aunque 
existen dos miembros de la familia Neurl 
en mamíferos (Neurl1 y Neurl2), ambos 
genes son dispensables para el desarrollo 
embrionario, ya que ratones doble mutantes 
para estos genes no muestran alteraciones 
del desarrollo y son viables (Vollrath et al., 
2001, Ruan et al., 2001, Koo et al., 2007). 
En el caso de los dos miembros de la familia 
Mib, Mib1 (Itoh et al., 2003) y Mib2 (Koo et 
al., 2005b), sólo Mib1 es necesario para el 
desarrollo, aunque es importante resaltar que 
Mib2 se expresa fuertemente en tejido adulto 
(Koo et al., 2005b). Mib1 interactúa de manera 
específica con los ligandos de ambas familias 
de Notch, Delta-like (Chen and Casey Corliss, 
2004, Itoh et al., 2003) y Jagged (Hansson et 
al., 2010, Koo et al., 2007), lo que es un punto 
de regulación de la activación de la vía en la 
célula señalizadora. La proteína de 110KDa 
codificada por Mib1 contienen cinco dominios, 
dos dominios Mib-Herc2 separados por un 
ZZ Zinc finger, seguidos por dos dominios 
Mib que son responsables de la interacción 
con los ligandos, ocho repeticiones de 
ankirina que doblan la proteína sobre si 
misma y en el extremo C-terminal, tres RING 
fingers separados por un dominio en espiral, 
responsables de la actividad enzimática de la 
proteína (Barsi et al., 2005) (Fig. 4).
Mib1 se expresa de manera ubicua durante 
el desarrollo embrionario murino (Barsi et 
al., 2005). Diferentes estudios que muestran 
su importancia durante varios procesos del 
desarrollo y la inactivación de Mib1 mediante 
gene targeting produce fenotipos similares a la 
pérdida de función de Notch. Mib1 se requiere 
para el desarrollo de la vasculatura donde su 
inactivación produce un fenotipo similar a la 
perdida de función de Dll4, para el desarrollo 
de las células epiteliales de la piel y las crestas 
de ectodermo del cerebelo donde produce un 
fenotipo similar a la inactivación de Jag2 (Koo 
et al., 2007). Mib1 también se requiere para 
el desarrollo de los tubos colectores renales 
(Jeong et al., 2009), la formación de células b 
pancreáticas (Horn et al., 2012), el desarrollo 
de las células T (Shah et al., 2012, Jeong et al., 
2012), la maduración de las células secretoras 
en el sistema gastrointestinal (Capoccia et 
al., 2013) y en el control de la neurogénesis 
y gliogénesis en la médula espinal (Kang et 
al., 2013). 
La importancia de Mib1 durante el 
desarrollo embrionario y el hecho de que 
ambas familias de ligandos de Notch son sus 
substratos, hacen de esta E3 ubiquitina ligasa 
una poderosa herramienta para estudiar la 
función de la vía de señalización Notch durante 
el desarrollo. Mib1 es uno de los primeros 
miembros de toda la vía de señalización en 
actuar, se expresa de manera ubicua y regula 
la señalización proveniente de todos los 
ligandos, de manera que su inactivación nos 
permite estudiar la pérdida total de la vía de 
Notch. La inactivación especifica de tejido de 
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Mib1 durante el desarrollo permitirá distinguir 
diferentes efectos en la señalización por 
Notch dependiendo del origen de la señal y 
las diferentes funciones de cada ligando.
Activación de la vía de NOTCH
La interacción ligando-receptor permite 
que Mib ubiquitinice el dominio intracelular del 
ligando, lo que promueve su internalización y 
endocitosis (Itoh et al., 2003). La endocitosis 
del ligando arrastra el NECD de Notch, 
produciendo un cambio conformacional que 
libera el sitio de corte S2 (Parks et al., 2000) 
(Fig. 5). La liberación del sitio S2 permite 
a una metaloproteasa de la familia ADAM 
cortar el NECD (Hartmann et al., 2002), el 
cuál es finalmente endocitado junto al ligando 
en la célula señalizadora. Inmediatamente 
después, una actividad  g-secretase corta el 
receptor por el sitio S3, liberando el NICD en 
el citoplasma de la célula receptora (Okochi 
et al., 2002) (Fig. 5). Las NLS de NICD 
favorecen su translocación al núcleo, donde 
a través del dominio RAM23 se une a factor 
de transcripción CSL o RBPJK (Tamura et al., 
1995).
En ausencia de activación de la vía de 
Notch, RBPJK está unido a represores 
transcripcionales como Mint (Tanigaki and 
Honjo, 2007) o SMRT (Silencing mediator 
of retinoic and thyroid hormone receptors) 
(Mumm and Kopan, 2000) inhibiendo la 
expresión génica. La interacción de RBPJK 
con el NICD de Notch hace que estos 
represores sean liberados y activadores 
transcripcionales como master mind (Maml) 
(Wu et al., 2000) son reclutados para formar 
un complejo activador que inicia la expresión 
de los genes diana de la vía (Fig. 5).
Los genes diana de la vía más estudiados 
en el contexto del desarrollo cardiovascular 
son los factores de transcripción basic-helix-
loop-helix (bHLH) de las familias Hes (hairy 
and enhancer of split) y Hey/Hesr/HRT/
HERP/HESR (Hes-related repressor protein) 
(Kokubo et al., 1999, Iso et al., 2001, Iso et 
al., 2003) (Fig. 5). El espectro de genes diana 
directos de la vía es muy amplio y varios 
genes pueden activarse en paralelo a la vía 
incluyendo el oncogén c-myc, otra proteína 
bHLH que promueve el crecimiento celular 
en leucemia (Palomero et al., 2006, Weng et 
al., 2006), el regulador del ciclo celular p21 
(Devgan et al., 2005, Rangarajan et al., 2001) 
o el factor de transcripción represor Snail1 
que se requiere para la EMT y el desarrollo 
valvular (Timmerman et al., 2004, Sahlgren et 
al., 2008) (Fig. 5). El regulador negativo de la 
vía NRARP (Notch regulated ankyrin repeat 
protein) (Krebs et al., 2001, Lamar et al., 
2001) es también una diana directa de Notch 
(Fig. 5).
NOTCH y el desarrollo cardiaco
Notch está implicada en diversos procesos 
durante el desarrollo del corazón (High and 
Epstein, 2008, Rones et al., 2000, Nemir et 
al., 2006, de la Pompa and Epstein, 2012). 
En el embrión de ratón a mitad de 
gestación, Notch1 está activo en todo el 
endocardio del AVC y del OFT donde se 
formarán las válvulas (Del Monte et al., 
2007). Durante la formación de los primordios 
valvulares, Notch activa la expresión de 
Snail1 que reprime la cadherina del endotelio 
vascular (VE-C o Cdh5) permitiendo que las 
células del endocardio en el AVC y el OFT 
realicen EMT e invadan la gelatina cardiaca 
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entre el endocardio y el miocardio para formar 
los primordios valvulares (Timmerman et al., 
2004). Hey1 y Hey2 restringen la expresión de 
Bmp2 exclusivamente al miocardio del AVC, 
de manera que las válvulas sólo se formen en 
este área (Rutenberg et al., 2006, Kokubo et 
al., 2004). Aunque Notch no regula la expresión 
de los genes Hey en el miocardio (Timmerman 
et al., 2004), la sobreexpresión del N1ICD en 
el miocardio produce la expresión ectópica 
de los genes Hey y bloquea la formación del 
AVC (Watanabe et al., 2006, Luna-Zurita et 
al., 2010). El doble mutante Hey1;Hey2 no 
produce colchones del endocardio y la EMT 
está totalmente inhibida (Kokubo et al., 2005).
Aunque esté expresado por todo el 
endocardio en los ventrículos durante el 
desarrollo, Notch1 sólo está activo en las 
base de las trabéculas a E9.5 (Del Monte et 
al., 2007). Desde la base de las trabéculas 
Notch señaliza hacia el miocardio para inducir 
su diferenciación y proliferación que dará 
lugar a las trabéculas (Grego-Bessa et al., 
2007). El análisis de los mutantes estándar y 
específicos del endocardio de Notch1 y RBPJk 
revela que en estos ratones la trabeculación 
está severamente afectada, solamente 
algunas trabéculas menores y pobremente 
organizadas pueden observarse (Grego-
Bessa et al., 2007). El análisis molecular revela 
que durante la trabeculación Notch modula 
tres señales diferentes: EphrinB2 (Adams et 
al., 1999), que se expresa en el endocardio es 
una diana directa de Notch (Grego-Bessa et 
al., 2007), Nrg1 (Hertig et al., 1999) expresado 
en el endocardio es una diana indirecta de 
Notch pero su expresión depende tanto de 
Notch como de EphrinB2 (Grego-Bessa 
et al., 2007). Nrg1 induce la formación del 
sistema de conducción cardiaca, necesario 
para la maduración ventricular (Rentschler 
et al., 2002). La tercera vía de señalización 
es Bmp10 (Chen et al., 2004), expresado en 
el miocardio trabecular y cuya expresión se 
ve severamente reducida en los mutantes de 
Notch, sugiriendo que Notch es necesario 
para producir la señal que active Bmp10 en el 
miocardio (Grego-Bessa et al., 2007).
Notch está activo en el proepicardio y más 
tarde en el epicardio durante la formación 
de las células derivadas del epicardio. 
Notch modula la diferenciación celular en el 
proepicardio y posteriormente se requiere 
para la determinación arterial durante el 
desarrollo de la vasculatura coronaria que 
mantendrá el crecimiento del miocardio 
durante el desarrollo ventricular (del Monte et 
al., 2011, Grieskamp et al., 2011).

OBJECTIVES
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The observations that Mind bomb 1 is expressed ubiquitously in the developing embryo (Barsi 
et al., 2005), that it is necessary for the correct development of the mammalian embryo (Koo et 
al., 2007), that its substrates are all the Notch ligands (Koo et al., 2005a) and that more than 
one ligand may be expressed in a given cardiac tissue (ie: myocardium, epicardium) makes the 
mouse with a conditional mutation in this E3 ubiquitin ligase a perfect tool to study the role of the 
Notch ligands in heart development. Notch has been demonstrated to regulate the development 
of the valves (Timmerman et al., 2004, Kokubo et al., 2004, Luna-Zurita et al., 2010) and the 
cardiac chambers (Grego-Bessa et al., 2007). One obvious implication of these developmental 
studies is that alterations of NOTCH signalling in human cardiac development may lead to CHD. 
In this study we have generated cardio-specific mouse loss-of-function models of Mib1, in 
order to evaluate the effect of the abrogation of all the input of the ligands expressed in a given 
cardiac tissue.
Specific aims:
Study the phenotypic consequences of Notch ligands signalling abrogation in the heart: 
Mib1 in the endocardium: Mib1flox;Tie2-Cre.
Mib1 in the myocardium: Mib1flox;cTnT-Cre. 
Mib1 in endocardium and myocardium: Mib1flox;Nkx2.5-Cre.
Thus, we will study the consequences of Mib1 targeted inactivation in the development of the 
cardiac valves and the chambers, paying special attention to the potential implication in cardiac 
disease derived from the incorrect development of these structures (Grego-Bessa et al., 2007, 
Garg et al., 2005).

MATERIAL AND 
METHODS
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Mouse strains and genotyping. The 
mouse strains used were Tie2-cre (Kisanuki et 
al., 2001a), Nkx2.5-cre (Stanley et al., 2002), 
cTnT-cre (Jiao et al., 2003), Islet1-Cre (Cai et 
al., 2003) and Mib1flox (Koo et al., 2007). For 
simplicity, we use Mib1flox;Tie2-cre to refer 
to Mib1flox/flox;Tie2-cre/+ mice, Mib1flox;cTnT-
cre to refer to Mib1flox/flox;cTnT-cre/+ mice, 
Mib1flox;Nkx2.5-cre for Mib1flox/flox; Nkx2.5-cre/+ 
mice. All groups of mice were a mix of males 
and females. Genotyping of the different genes 
was performed using the following primers: 
Tie2-Cre (forward, 5’-GGGAAGTCGC 
AAAGTTGTGAGTT-3’; reverse, 
5’-CTAGAGCCTGTTTTGCACGTTC-3’), 
annealing temperature 60ºC, product 
length 500bp; Nkx2.5-Cre (forward, 
5’-GCGCACTCACTTTAATGGGAAGAG-3’; 
reverse, 
5’-GCCCTGTCCCTCAGATTTCACACC-3’), 
annealing temperature 60ºC, product 
length 583bp; cTnT-Cre (forward, 
5’-TACTCAAGAACTACGGGCTGC-3’; 
reverse 
5’-GCACTCCAGCTTGGTTCCCGA-3’), 
annealing temperature 60ºC, product 
length 350bp; Islet1-Cre (forward, 
5’-GCTGAAGGATGCCCAGAAGG-3’, 
reverse, 
5’-AACTTGCACCATGCCGCCCAC-3’), 
annealing temperature 60ºC, product 
length 350bp; Mib1flox (forward, 
5’-ACACCCAGAGGAAGCCCTAC-3’, 
reverse, 5’-CTCACATCACCAAAGGATTGT-3’ 
and conditional 
5’-CCAGTCATAGCCGAATAGCC-3’), forward 
and reverse primers are used to obtain the 
WT band, forward and conditional are used to 
obtain the transgenic band. All three primers 
can be used in the same time in the PCR mix. 
Annealing temperature 60ºC, product length 
500bp for the transgenic band and 320bp for 
the WT band. Animal studies were approved 
by the CNIC Animal Experimentation 
Ethics Committee. All animal procedures 
conformed to EU Directive 2010/63EU and 
Recommendation 2007/526/EC regarding the 
protection of animals used for experimental 
and other scientific purposes, enforced in 
Spanish law under Real Decreto 1201/2005.
Tissue Processing. Mouse embryos 
were fixed in 4% paraformaldehyde (PFA) at 
4ºC overnight. Embedding was performed 
following dehydratation using graded ethanol 
series, xylene washes and final paraffin steps. 
Histology, and in	 situ	 hybridization. 
H&E was performed according to standard 
protocols. In situ hybridization was performed 
following published protocols (Kanzler et al., 
1998).
3D episcopic reconstruction. 3D models 
were performed in Dr. T. Mohun’s laboratory 
in the MRC National Institute for Medical 
Research in London following already 
published protocols (Mohun and Weninger, 
2012a, Mohun and Weninger, 2012b, Mohun 
and Weninger, 2012c).
Scanning Electron Microscopy (SEM). 
Hearts were analysed in Dr. D. Sedmera’s 
laboratory in the Institute of Anatomy, First 
Faculty of Medicine, Charles University in 
Prague.
Immunohistochemistry. Antibodies 
to Dll4 (1:100, SC28915, Santa Cruz 
Biotechnology) and Jag1 (1:100, 2620, 
Cell Signaling Technology) were applied 
overnight, followed by a 1-h incubation with 
rabbit horseradish peroxidase (HRP)-coupled 
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secondary antibody (1:100 in 5% BSA, 
P0447, Dako Cytomation). The signal was 
amplified using a tyramide amplification kit 
(TSA) coupled to Cy3 (1:100, NEL744, Perkin 
Elmer). Staining with antibodies to N1ICD 
(1:100, 2421, Cell Signaling Technology) was 
performed following the protocol described in 
(Del Monte et al., 2007).
Proliferation analysis and quantification. 
Cell proliferation was analyzed by detection 
of BrdU incorporation. Pregnant females 
were intraperitonally injected with 300ul BrdU 
at 10mg/ml and two hours later embryos 
were isolated in sterile PBS. Neonates were 
intraperitonally inject with 50ul BrdU at 10mg/
ml and the hearts were after two hours 
dissected. Embryos or neonatal hearts were 
fixed overnight in PFA 4%. BrdU positive 
cells were detected following the protocol 
described in (Del Monte et al., 2007). Antibody 
to BrdU (1:50, B2531, Sigma-Aldritch). Total 
cells and BrdU-positive cells in the compact 
myocardium were counted in sections (at least 
five) in three embryos of each genotype.
Hypertrophy analysis and quantification. 
Hypertrophy was analyzed by measuring the 
relative cell area in WT and Mib1flox;cTnT-cre 
hearts stained with tetramethylrhodamine-
conjugated wheat germ agglutinin (1:100, 
W849, Molecular Probes). Hearts were 
fixed overnight in 4% paraformaldehyde and 
embedded in paraffin. At least 100 cells were 
measured per section, and at least three 
sections were measured per embryo. Three 
embryos were analyzed per genotype.
Microscopy. Stained sections or cells 
were viewed with an Olympus BX51 micro-
scope fitted with a Nikon DP71 camera and 
CellA controller software.
Semi- and Quantitative RT-PCR of 
embryonic mouse heart. E9.5 for semi-
quantitative and E15.5 for quantitative WT and 
mutant mice were dissected in ice-cold PBS 
and the whole heart was separated from the 
rest of the body. Total RNA was purified using 
TRIzol (Invitrogen). cDNA was synthesized 
with SuperScript III First Strand (Invitrogen), 
with 1 μg total RNA per reaction. 
Semi-quantitative PCR was performed 
with the following primers: Hey1 (forward, 
5’-AGGGTGGGATCAGTGTGC-3’; reverse 
5’-TGCTTCTCAAAGGCACTG-3’) annealing 
temperature 56ºC, product length 355bp 
(Timmerman et al., 2004); Hey2 (forward, 
5’-GAGGCAGTGATGACATCC-3’; reverse, 
5’-CCCTGATGGCATCCGAAGAGC-3’), 
annealing temperature 58ºC, product length 
273bp (Timmerman et al., 2004); Hey3 (forward, 
5’-GGTCCCCACTGCCTTTGAGA-3’; reverse 
5’-AGGATGGCGAGCTGACTGTTC-3’), 
annealing temperature 65ºC, product length 
381bp (Wang et al., 2002), Snail1 (forward, 
5’-GGAAGCCCAACTATAGCGAGC-3’; 
reverse 
5’-CAGTTGAAGATCTTCCGCGAC-3’), 
annealing temperature 57ºC, product length 
424bp (Veltmaat et al., 2000), Nrg1 (forward, 
5’-GCACTTGCACAAGTATCTTGAGGG-3’; 
reverse 
5’-CCTCCCAGATTGAAAGAGATGAAA-3’) 
annealing temperature 67ºC, product length 
531bp (Miyazaki et al., 2004), Bmp10 (forward 
5’-ACCAAGCTGAGGACACCGGAAGG-3’; 
reverse 
5’-CTTCGTGGGCACACAGCAGGCTTT-3’) 
annealing temperature 59ºC, product length 
485bp (Grego-Bessa et al., 2007), Actin (forward, 
5’-GGACCTGGCTGGCCGGGACC-3’, 
reverse 
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5’-GCGGTGCACGATGGAGGGGC-3’), 
annealing temperature 62ºC, product length 
583bp (Bi et al., 1999). 
Quantitative PCR was performed with Power 
SYBR Green Master Mix (Applied Biosystems, 
4367659) and the following prim ers: Tbx20 
(forward, 5′-TATTCAGCATACTCCTAC-3′; 
reverse, 5′-GTTAGTCTTGTCAATACG-3′); 
Anf (forward, 
5′-CCTGCCTTCATCTATCAC-3′; reverse, 
5′-TGAGGATCTACCTTAATATGC-3′); Bmp10 
(forward, 5′-CCATCTCCATCCTCTATT-3′; 
reverse, 5′-TCTCCTCTCCTATCTACA-3′); 
Cx40 (forward, 
5′-AGCAACATACCAGATAGA-3′; reverse, 
5′-GCAGATTACTTGATGAATAC-3′); n-Myc 
(forward, 5′-GACGAGGAGGAAGATGAA-3′; 
reverse, 5′-CTTGTTGTTAGAGGAGGAA-3′); 
Hey2 (forward, 
5′-GCTCATTGACACCAACTC-3′; reverse, 
5′-ATTGCCTGCTTCTTCTCT-3′); β-actin 
(forward, 5′- ATCTTCCGCCTTAATACT-3′; 
reverse, 5′- GCCTTCATACATCAAGTT-3′).
RNA-seq. RNA was isolated from the 
ventricles of 16 WT and 16 Mib1flox;cTnT-cre 
hearts at E14.5 and then pooled into four 
replicates. RNA was sequenced with the GAIIx 
sequencer. The sequencing protocol was 
single-end 75-bp elongation. The reads were 
first aligned using Bowtie version 0.12.7 and 
then mapped to the latest Ensembl transcript 
set using RSEM v1.16 (Li and Dewey, 2011). 
Genes showing altered expression with 
adjusted P < 0.05 were considered differentially 
expressed. Gene Ontology analysis was 
performed using Ingenuity.
Western blots from embryonic samples. 
Hearts from E13.5 embryos were dis sected 
and lysed in RIPA buffer (50 mM Tris, pH 7.4, 
150 mM NaCl, 1% Triton X-100, 0.25% sodium 
deoxycholate and 1 mM EDTA) containing 
protease inhib itor cocktail (Roche) and MG-
132 (Calbiochem). Total proteins (25 μg) were 
separated by SDS-PAGE and transferred to 
a polyvinylidene fluoride (PVDF) membrane. 
Blots were incubated overnight with primary 
antibodies. Antibodies to Mib1 (Jin et al., 
2002) were used at 1:1,000, and antibodies to 
N1ICD and Jagged1 (1:1,000) were the same 
as those used for immunostaining. Other 
primary anti bodies used were antibodies 
to N2ICD (1:1,000, ab52302, Abcam), Dll4 
(1:500, ab7280, Abcam), GFP (1:400, SC9996, 
Santa Cruz Biotechnology), α-tubulin (Sigma, 
T8203, 1:4,000) and β-actin (1:6,000, Sigma, 
A5441). HRP-coupled sec ondary antibodies 
(Dako) were used at 1:5,000 dilution. Band 
intensities were quantified by densitometric 
analysis using ImageJ software.
Ultrasound. Mice were anesthetized by 
inhalation of isoflurane and oxygen (1.25% 
and 98.75%, respectively) and examined with 
a 30-MHz transthoracic echocardiography 
probe. Images were obtained with Vevo 
770 (VisualSonics, Toronto, Canada) from 
Mib1flox;cTnT-cre and WT littermates. Short-
axis, long-axis, B-mode and two-dimensional 
M-mode views were obtained as described 
previously (Cruz-Adalia et al., 2010). From 
these images, left ventricle function was 
estimated by the ejection fraction obtained from 
the M mode by a blinded echocardiography 
expert. For the ejection fraction measurements, 
a long- or short-axis view of the heart was 
selected to obtain an M mode registration 
in a line perpendicu lar to the left ventricular 
septum and posterior wall at the level of the 
mitral chordae tendinea. Ultrasound studies 
were performed in collaboration with Dr. J. 
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Borreguero (CNIC).
CMRI. Mice were anesthetized by 
inhalation of isoflurane and oxygen (5% and 
95%, respectively) and examined with a 
Bruker Biospec 70/210 at 7 T and a maximum 
gradient of 750 mT m−1. Echocardiograph 
(ECG) synchronization was performed with 
the Intragate function included in the CMRI 
software. ECG measures and breathing 
rhythm were monitored with a system for small 
animals compatible with MRI (model 1025, 
S.A. Instruments, Inc.). Data were acquired 
with the IntraGate_FLASH sequence at TE 
(echo time) = 2.4 ms and TR (repeti tion time) 
= 8 ms. The slice thickness was 1 mm and the 
field of view was 2.7 cm x 3 cm in a matrix of 
256 pixels x 256 pixels.
Studies in human subjects were performed 
with a 3-T clinical magnet (Ingenuity, Philips 
Medical Systems, Best, The Netherlands). 
Patients were scanned using 32-channel 
phased array surface coils as receivers and 
retro spective ECG gating. Images were 
obtained during end-expiratory breath holds. 
Segmented cine steady-state free precession 
was performed to acquire 10–15 contiguous 
short-axis slices covering both ventricles from 
the base to the apex and also four-chamber and 
two-chamber views with a slice thickness of 6 
mm. The structurally normal hearts analysed 
by CMRI were from healthy individuals 
with no mutations in MIB1. Left ventricular 
trabeculation was defined as myo cardium 
protruding from the left ventricular wall into 
the left ventricular cavity at the end-diastolic 
phase. To quantify left ventricular volume, left 
ventricular ejection fraction and compacted 
left ventricular mass, the endocardial border 
was traced to include papillary muscle and 
exclude trabeculation. To quantify global 
left ventricular mass, the endocardial border 
was traced to include pap illary muscles and 
trabeculation. The trabeculated left ventricular 
mass was calculated as (global left ventricular 
mass – compacted left ventricular mass), and 
the trabeculated left ventricular mass with 
respect to the total left ventricular mass was 
calculated as ((global left ventricular mass 
– compacted left ventricular mass)/global 
left ventricular mass) x 100. Left ventricular 
volume, compacted left ventricular mass 
and trabeculated left ventricular mass were 
indexed to the body surface area. The ratio 
of noncompacted to compacted myocardium 
was measured in short-axis views at the end-
diastolic phase, considering the segment 
with the most pronounced trabeculations as 
the noncompacted layer and the compacted 
myocardium as being perpendicular to this. We 
used the methods of Jacquier (trabeculated 
left ventricular mass above 20% of the total left 
ventricle (Jacquier et al., 2010)) and Petersen 
(noncompacted to compacted ratio >2.3 in the 
diastole (Petersen et al., 2005)) for the CMRI 
analysis, considering a diagnosis of LVNC 
by CMRI if at least one of those measures 
were positive. Mouse CMRI was performed in 
collaboration with Dr. J. Ruiz Cabello (CNIC). 
LVNC clinical phenotype evaluation 
and DNA collection. Clinical evalua tions and 
genetic studies were performed in accordance 
with human subject guidelines after informed 
consent according to the protocol approved by 
the Hospital Universitario Virgen de la Arrixaca, 
Instituto Cardiovascular Hospital Clínico 
San Carlos, Hospital General Universitario 
Gregorio Marañón, Hospital Universitario 
Puerta de Hierro and Hospital Universitario de 
La Princesa. We included 100 unrelated index 
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patients with an echocardiographic diagnosis 
of LVNC (48 of them familial), defined by 
the presence of at least three prominent 
trabeculations in the left ventricle and a ratio 
of noncompacted to compacted segment 
>2.0 at the end-diastolic phase (Stollberger 
and Finsterer, 2004, Stollberger et al., 2002). 
All subjects underwent a clinical evaluation, 
including an ECG and two-dimensional 
and Doppler echocardiography. A pedigree 
was drawn for each patient and first-degree 
relatives were screened with the same 
protocol. Patients were diagnosed by Dr. J. R. 
Gimeno (Hospital Clínico Universitario Virgen 
de la Arrixaca, Murcia). Blood samples were 
taken for genetic analysis and all patients 
and their relatives gave written informed 
consent. Genomic DNA for genetic analyses 
was extracted from peripheral lymphocytes. 
Patients positive for MIB1 mutations were then 
analyzed and found negative for altera tions in 
other genes previously related to LVNC (Captur 
and Nihoyannopoulos, 2010) (Ichida, 2009). 
The genes analyzed were MYH7, MYBPC3, 
TNNT2, TNNI3, TPM1, ACTC, MYL2, MYL3, 
TNNC, G4.5, LDB3 and LMNA. CMRI was 
performed on all patients with identified MIB1 
mutations, except in patients 2.I.3 and 2.I.4 
(Table 3), and in selected healthy individuals.
Identification of human MIB1	mutations. 
All human MIB1 coding exons were sequenced 
bidirectionally to search for sequence 
variations in the 100 patients analyzed and the 
family members of the two probands. Primer 
pairs for the 20 MIB1 exons were designed 
using the PrimerZ algorithm (Tsai et al., 
2007). PCR amplification was per formed with 
the Advantage Genomic PCR kit (Clontech). 
Human MIB1 muta tions were screened with 
the LIMSTILL platform (http://limstill.niob.
knaw.nl/). For controls, echocardiographic 
studies were carried out on 263 healthy 
volun teers. Blood from these volunteers was 
obtained and the two MIB1 exons that contain 
the identified mutations in the patients with 
LVNC were sequenced. All healthy volunteers 
were negative for these mutations.
URLs. PolyPhen-2 program, http://genetics.
bwh.harvard.edu/pph2/index.shtml; GERP, 
http://genome.ucsc.edu/; 1000 Genomes 
database, http://browser.1000genomes.org/
Homo_sapiens/Transcript/ProtVariations?db=
core;g=ENSG00000101752;r=18:19321281-
19450918;t=ENST00000261537; National 
Heart, Lung, and Blood Institute Grand 
Opportunity Exome Sequencing Project, 
https://esp.gs.washington.edu/drupal/; 
Genome-Wide Association Studies, http://
www.genome.gov/gwastudies/; Copy Number 
Variation, http://www.sanger.ac.uk/research/
areas/humangenetics/cnv/global_assess.
html; Genetic Association Database, http://
geneticassociationdb.nih.gov/cgi-bin/index.
cgi; International HapMap project, http://
hapmap.ncbi.nlm.nih.gov/.
Three-dimensional structure prediction 
for MIB1 and JAG1. In silico mod els of the 
MIB1 and JAG1 proteins were calculated 
using a de novo prediction method with a 
structural homolog comparison approach. 
The fasta sequence (1006 amino acids 
(aa)) of MIB1 (UniProtKB: Q86YT6, NCBI: 
NP_065825.1) and the fasta sequence (1218 
aa) of JAG1 (UniProtKB: P78504, NCBI: 
NP_000205) were submitted to the i-TASSER 
server (http://zhanglab.ccmb.med.umich.
edu/I-TASSER/) (Roy et al., 2010; Roy et al., 
2011; Zhang, 2008). The default values (no 
restriction or model templates) were used for 
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prediction. The more compact PDB model 
for MIB1 (C-score = –2.88) was loaded into 
the PyMOL program (PyMOL Molecular 
Graphics System, Version 1.4.1, Schrödinger, 
LLC., http://www.pymol.org/), and a new PDB 
model with a single mutated position (V943F) 
was generated. To validate the secondary 
structure of the transmembrane domain of the 
best PDB model for JAG1 (C-score = –1.37), 
the JAG1 fasta sequence was submitted to 
the Swiss-Model Portal with the MEMSAT 
option selected (http://swissmodel.expasy.
org/) (Arnold et al., 2006, Kiefer et al., 2009, 
Jones et al., 1994). The helix dihedral angles 
for the transmembrane domain in the JAG1 
PDB model were fixed using Swiss-PdbViewer 
v 4.04 (http://www.expasy.org/spdbv/). 3D 
models were performed by Dr. F. Martinez de 
Benito (CNIC).
Three-dimensional structure prediction 
for the MIB1 dimer. In silico models of the 
MIB1 WT homodimer (WT-WT) and the 
heterodimer (WT-V943F) were calculated 
by submitting PDB models of MIB1 and 
MIB1-V943F to the Hex server v6.9 (http://
hexserver.loria.fr/) (Ritchie, 2005, Ritchie et 
al., 2008, Ritchie and Venkatraman, 2010, 
Macindoe et al., 2010, Mustard and Ritchie, 
2005, Ritchie, 2003, Ritchie and Kemp, 2000). 
The docking method in dimer mode with 
shape plus electrostatic restriction was used 
for prediction and the minimal energy model 
for each dimer type was selected. 3D models 
were performed by Dr. F. Martinez de Benito 
(CNIC)
Three-dimensional structure prediction 
for the docking of JAG1 to the MIB1 dimer. 
In silico theoretical models of the docking of 
JAG1 to MIB1 dimers (WT-WT homodimers 
and WT-mutant heterodimers) were calculated 
using a docking prediction method. PDB 
models for JAG1 as the receptor and the 
MIB1 dimer as the ligand were submitted 
to the ClusPro server v2.0 (http://cluspro.
bu.edu/) (Kozakov et al., 2010, Kozakov et al., 
2006, Comeau et al., 2004). The hydrophobic-
favored model compatible with the protein 
domains and biological function for each MIB1 
dimer type was selected. PyMOL v1.4.1 was 
used for alignment, visualization options and 
model decoration. 3D models were performed 
by Dr. F. Martinez de Benito (CNIC).
Isolation of whole mononuclear cells 
from peripheral blood. EDTA-treated 
peripheral blood from patients and control 
subjects was diluted in one volume of PBS and 
slowly layered over a Ficoll-Hypaque solution. 
After centrifugation at 900g with no brake, the 
mononuclear cell layer was collected from the 
top of the Ficoll-Hypaque solution and washed 
twice with PBS to remove most of the platelets. 
Pelleted cells were lysed in RIPA buffer and 
total proteins (25 μg) were separated by SDS-
PAGE and transferred to a PVDF membrane. 
Blots were incubated overnight with the 
primary antibodies to N1ICD, Mib1 and 
β-actin described above and under the same 
conditions.
T cell culture. After isolation from 
peripheral blood, whole mononuclear cells 
were seeded at 1–2 x 106 cells per ml in 
RPMI medium containing 10% FBS and 5 μg/
ml phytohemagglutinin (PHA, Sigma). After 
2 days, cultures were washed with PBS to 
remove PHA and the cells were stimulated 
with interleukin-2 (IL-2) (50 U/ml). Density was 
maintained at 1–2 x 106 cells per ml for 7 days.
T cell gene expression analysis. For 
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qPCR assays, cells were cultured in IL-2–free 
medium overnight and then collected for RNA 
extraction with an RNeasy Mini Kit (Qiagen). 
RNA was reverse transcribed to cDNA using 
a Superscript III First-Strand kit (Invitrogen). 
qPCR was performed using the Power 
SYBR Green system (Applied Biosystems). 
Relative expression was cal culated by the 
delta cycle threshold (ΔCt) method. The 
primers used were as follows: DTX1: forward, 
5′-ACGAGAAAGGCCGGAAGGT-3′; reverse, 
5′-GGTGTTGGACGTGCCGATAG-3′; 
GATA3: forward, 5’-TGGGCTCTACTAC 
AAGCTTCACAATAT-3’;reverse, 
5′-TTGCTAGACATTTTTCGGTTTCTG-3′; 
GUSB:forward, 
5′-CAACGAGCCTGCGTCCCACC-3′; 
reverse, 5′-ACGGAGCCCCCTTGTCTGCT-2′ 
(Van de Walle et al., 2009). qPCR assays were 
also performed with the following NOTCH 
target genes: HES1, NOTCH3, NRARP, TCF7, 
HEY1 and c-MYC, whose expression was not 
significantly affected. For primer sequences, 
see (Van de Walle et al., 2009).
Semiquantitative RT-PCR and qPCR 
analysis of MIB1	 mutant tran scripts. The 
cDNA generated from T cells of patients 
was used to analyse the effect of the V943F 
and R530X mutations on the expression 
of the cor responding mutant transcripts. 
An initial estimate of the expression of 
these mRNAs was achieved by RT-PCR 
using primers spanning both mutations. 
For V943F the primers were forward, 
5′-AAAGTTCAGAAAGATGCCACTG-3′ and 
reverse, 5′-CATTCACTCATGCGGTCTC-3′; 
for R530X, the prim ers were forward, 
5′-TGGCCACACAGCTATGCAAGT-3′ 
and reverse, 
5′-TCCCCTTAGTGCAGCATGATG-3′. The 
PCR products (266 bp for V943F and 433 
bp for R530X) were cloned into the pGEM-T 
plasmid and 24 clones of each mutation were 
sequenced to estimate the percentage of WT 
compared to mutant transcripts.
Mutant transcripts were quantified by 
qPCR using primers to amplify the MIB1 
cDNA 5′ and 3′ ends of the mutations. 
The primers used were forward, 
5′-CATTGGCATTCGATGGAA-3′ and reverse, 
5′-CTCTGGCTGTAATCTTCTTAG-3′, which 
are common to both mutations. To amplify the 
3′ end of R530X, we used the primers forward, 
5′-TTAACAGTTCAAGCAATT-3′ and reverse, 
5′-GCAGGAATCATTATTAACAAG-3′. 
To amplify the 3′ end of V943F, 
5′-GATAGGACATTCACTCAT-3′.
Generation and cloning of MIB1	
mutations. Complete cDNA for MIB1 was 
obtained from clone IMAGE 40008395. The 
sequence was amplified with Phusion High-
Fidelity DNA Polymerase (NEB) with primers 
containing BamHI and EcoRI sites, and cloned 
in frame with an HA epitope into the BglII-
EcoRI sites of pCELF (a gift from A. Martín-
Pendás). MIB1 cDNA was also cloned in 
frame with Flag, CFP and YFP into the BamHI 
and EcoRI sites of pEF-Flag (Copeland and 
Treisman, 2002), pEYFP-N1 and pECFP-N1 
(Invitrogen), respectively. The constructs were 
sequenced and HA-MIB1 was then cloned 
into the BamHI-EcoRI sites of pCS2. Point 
mutations were introduced into the pCS2-MIB1 
and pECFP-N1-MIB1 sequence using the 
QuikChange II XL site-directed mutagenesis 
kit (Agilent Technologies).
For V943F, we used the primers MIB1 
V943F forward (5′-GGACAAGGATAATACCA 
ATTTCAATGCAGATGTGCAA-3′) and MIB1 
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V943F reverse (5′-TTGCACATCTGCATTG 
AAATTGGTATTATCCTTGTCC-3′). 
For R530X, we used the primers 
MIB1 R530X forward (5′- 
GAATGCTCGAAACAAGCGCTGACA 
GACACCACTTCATATTG-3′) and MIB1 R530X 
reverse (5′-CAATATGAAGTGGTGTCTGTCA 
GCGCTTGTTTCGAGCATTC-3′). 
For the zebrafish dominant-negative 
mutation mib1ta52b (M989R), we 
used the primers MIB1 M989R forward 
(5′-TCAACTCTGTGGAGACCGCAGGAGT 
GAATGTCCTATCTGTC-3′) 
and MIB1 M989R reverse 
(5′-GACAGATAGGACATTCACTCCTGCGG 
TCTCCACAGAGTTGA-3′). The mutant 
nucleotides are bold and underlined. All point 
mutations were sequence verified.
Transfections and MIB1 functional 
assays. Functional assays were performed 
as described (Itoh et al., 2003) with slight 
modifications. HEK293 cells were co-
transfected with 8 μg total DNA (pcDNA3-
JAGGED1, pNA3-GFP-ubiquitin and the 
different pCS2-HA-MIB1 and pCEFL-Flag-
MIB1 constructs) using Lipofectamine Plus 
Reagent (Life Technologies). 24 h after 
transfection, cells were incubated with 5 μM 
MG-132 (Calbiochem) for a further 4 h and 
then lysed in IONIC buffer (50 mM Tris, pH 
8, 150 mM NaCl, 0.5% NP40, 0.5% sodium 
deoxycholate and 0.05% SDS) containing 
protease inhibitor cocktail (Roche) and 10 μM 
MG-132. One-fifth of the precleared lysate 
from a 100-mm dish was immunoprecipitated 
by overnight incubation at 4 °C with Jag1-
specific antibody (SC-6011, Santa Cruz 
Biotechnology, 1:100) followed by incubation 
with protein G Sepharose (GE Healthcare Bio-
Sciences) for 3 h at 4°C. The Sepharose bead–
protein pellets were washed six times with ice-
cold IONIC buffer and boiled in 2x SDS-PAGE 
sample buffer containing 50 mM dithiothreitol 
(DTT). Immunoprecipitated proteins and total 
lysates were analyzed by SDS-PAGE and 
transferred to a PVDF membrane. Blots were 
incubated overnight with antibodies to GFP 
(1:400, SC9996, Santa Cruz Biotechnology), 
HA (Santa Cruz, sc-805, 1:200), Flag (Sigma, 
F7425, 1:1,000) and Jag1, Mib1 and β-actin 
under the same condi tions described above.
FRET analysis. Pairwise combinations 
of 0.5 μg pEYFP-C1 plasmid encoding YFP-
tagged WT MIB1 and 0.5 μg pECFP-C1 
plasmid encoding CFP-tagged WT, V943F or 
R530X MIB1 were co-transfected in HEK293 
cells using Lipofectamine Plus Reagent 
(Life Technologies). For controls, cells were 
trans fected with plasmids encoding only the 
fluorescent proteins or with combi nations of 
these plasmids with the plasmid encoding 
YFP-tagged WT MIB1. FRET acceptor 
photobleaching analysis was performed with 
a Leica TCS SP5 confocal microscope.
Coimmunoprecipitation assays. We 
performed the dimerization assay described 
in (Zhang et al., 2007b) with slight variations. 
Briefly, HEK293 cells were transiently co-
transfected with 5 μg each of pCS2-HA-
MIB1 and pCEFL-Flag-MIB1 constructs 
using Lipofectamine Plus Reagent (Life 
Technologies). For the Mib1-Jagged1 inter-
action assay, HEK293 cells constitutively 
expressing Jagged1 (Chapman et al., 2006) 
were transfected with 5 μg of pCEFL-Flag-
MIB1 constructs in the same conditions. 
Cells were harvested 24 h after transfection 
in IONIC buffer containing protease 
inhibitor cocktail (Roche) and MG-132. For 
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coimmunoprecipitation, lysates from 100-
mm dishes were centrifuged and incubated 
with anti-Flag M2 affin ity gel (Sigma, A2220) 
for 4 h at 4 °C with gentle rocking. After six 
washes with lysis buffer, proteins were eluted 
with 2x SDS-PAGE sample buffer containing 
50 mM DTT and electrophoresed in SDS 
polyacrylamide gels followed by west ern 
blotting. Coimmunoprecipitated HA-MIB1, 
Flag-MIB1 and Jagged1 were detected as 
described above.
Luciferase assays. HEK293 cells 
constitutively expressing Notch1 (Chapman 
et al., 2006) were co-transfected with the 
Notch reporter plasmid pGL3-10xCBF1-Luc 
(Koibuchi and Chin, 2007) and pGL3-Renilla 
luciferase at a 5:1 ratio using Lipofectamine 
Plus Reagent (Life Technologies). In parallel, 
Jag1-HEK293 cells (Chapman et al., 2006) 
were transfected with one of the various 
MIB1 plasmids. At 24 h after transfection, 
Notch1-HEK293 and Jag1-HEK293 cells 
were cocultured in 24-well plates; 48 h later, 
the firefly and Renilla luciferase activities were 
measured using the Dual Luciferase Assay 
System (Promega). Data are expressed 
as ratios of firefly to Renilla luciferase. 
Experiments were performed in quadruplicate 
samples.
MIB1	 functional assays in zebrafish. 
Zebrafish (Danio rerio) were maintained 
and raised under standard conditions at 28 
°C. Transgenic Tg(mlc2a:GFP) embryos 
were used to visualize heart development. 
The Tg(mlc2a:GFP); mibta52b/ta52b line was 
generated by standard crossing of individual 
lines and was used to obtain mib1 mutants for 
use as phenotype controls. Capped mRNA 
encoding the human M989R, R530X or V943F 
MIB1 mutations were generated by using 
the mMESSAGE mMACHINE kit (Ambion) 
from pCS2-MIB mutant variants. Capped 
mRNAs were microinjected under a range of 
concentrations into embryos at the one- or 
two-cell stage. Capped GFP and WT MIB1 
mRNAs were used as microinjection controls. 
Embryos were allowed to develop at 28 °C. 
Twenty-four hours after fertilization, embryos 
were incubated in water containing 0.2 mM 
1-phenyl-2-thio-urea (Sigma) to prevent 
pigmentation. The numbers of embryos 
showing a WT or dysmorphic phenotype were 
counted at 72 h.p.f. Pictures were taken at 80 
h.p.f. using a dissection microscope equipped 
for epifluorescence (MZF16FA, Leica) and a 
digital camera (DFC310FX, Leica). At least 
100 embryos per condition were analyzed in 
each experiment.
Zebrafish Notch reporter assay. 
Tg(Tp1bglob:eGFP)um14 is a transgenic 
Notch-responsive zebrafish line harboring 
a construct with 12 RBPJK binding sites 
upstream of the β-globin minimal promoter 
and the eGFP reporter gene (Parsons et al., 
2009). Tg(Tp1bglob:eGFP)um14 embryos were 
injected at the one- or two- cell stage with 
capped mRNAs encoding the M989R, R530X 
or V943F MIB1 mutations and allowed to 
develop at 28 °C. At 24 h.p.f. Fish embryos 
were incubated in water containing 0.2 mM 
1-phenyl-2-thio-urea (Sigma) to prevent 
pigmentation. At 32 h.p.f., pictures were taken 
of groups of 20–25 embryos (three Petri 
dishes with approximately 75 embryos each; 
MZF16FA, Leica), and the average intensity 
in the green channel in at least 12 pictures 
per experiment was measured with Adobe 
PhotoShop CS3 Extended (Adobe Systems 
Incorporated). GFP fluores cence intensity 
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was compared with that of control uninjected 
larvae.
Statistics. Statistical analyses were 
performed using Student’s t test in Microsoft 
Excel 14.1.4. Data are presented as means ± 
s.e.m., unless otherwise indicated. Differences 
were considered statistically significant at P < 
0.05.
RESULTS
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The Notch signalling pathway 
and heart development
To study the role of Mib1 in heart 
development we bred mice bearing a Mib1 
conditional loss-of-function allele with three 
specific heart Cre drivers. Tie2-Cre active in 
the endocardium and vascular endothelium 
from E7.5 onwards (Kisanuki et al., 2001b), 
Nkx2.5-Cre active in the endocardium and the 
myocardium from E7.5 (Stanley et al., 2002) 
but with an stronger expression in the SHF, 
and the myocardium specific cTnT-Cre (Jiao 
et al., 2003) line active from E8.0. This will 
allow us to interrupt Notch signalling at the 
beginning of the chain of events allowing us 
to study the pathway from a “signalling cell” 
point of view 
The Notch signalling pathway shows a 
complex expression pattern in the heart (Fig. 
6). At E9.5, Mib1 is expressed ubiquitously, and 
in the heart it can be seen in the valvulogenic 
regions and in the chambers. Interestingly, 
it is expressed in both endocardium and 
myocardium since early developmental 
stages. This expression in maintained at 
E11.5 (Fig. 6 A). There are two Notch ligands 
differentially expressed in the heart; Delta4 
is expressed in the endocardium of both the 
valvulogenic regions, AVC and OFT, and the 
chambers (Fig. 4 B). Jagged1 is expressed 
in the myocardium of the chambers and in 
the endocardium of the valvulogenic regions 
(Fig. 6 C). The inactivation of Mib1 in the 
endocardium or the myocardium would allow 
us to determine the contribution of each 
Notch ligand to cardiac chamber and valves 
development in the heart.
First, we studied the expression and the 
activity of the pathway in our Mib1-cardio-
specific mutant mice. At E9.5 Notch1 is active 
in the valvulogenic regions and in the base 
of the trabeculae in the ventricle, as revealed 
by immunostaining using an antibody that 
recognizes the intracellular domain of the 
receptor (N1ICD) (Del Monte et al., 2007) (Fig. 
6). Later on, at E11.5, N1ICD is detected in the 
endocardium of the valves but the restriction 
expression in the trabeculeae is lost, and 
N1ICD is found throughout the endocardium 
(Fig. 6 D). N1ICD staining disappears in the 
heart of E9.5 Mib1flox;Tie2-Cre embryos (Fig. 
6 E). In Mib1flox;cTnT-Cre mice, Notch1 activity 
is severely reduced in the endocardium of 
the chambers but can still be detected in the 
endocardium of the valvulogenic regions of the 
heart (Fig. 6 E). In the case of Mib1flox;Nkx2.5-
Cre mice, N1ICD staining is strongly reduced 
both in the chambers and in the valvulogenic 
area (Fig. 6 E). The differential effects on 
Notch1 activity observed in the different 
mutants genotypes is very likely due to the 
different tissue specificity of the drivers. 
These results identify Notch as an important 
pathway involved in heart development, being 
expressed from early on. The different pattern 
of expression of the Notch ligands present in 
the heart, and the fact that Mib1 regulates the 
two of them, will allow us to dissect their role in 
the distinct areas of the developing heart. But 
even if ligands or modulators are expressed 
in the different tissues of the heart, Notch1, 
and therefore the pathway, is only active 
in the endocardium. This suggests that the 
endocardium is the key tissue directing heart 
development.
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Figure 6 Notch and cardiac development.
Notch elements are expressed at different stages of heart development. (A-F) Transverse sections of 
E9.5 and E11.5 of wild-type (WT), Mib1flox;Tie2-Cre, Mib1flox;cTnT-Cre and Mib1flox;Nkx2.5-Cre hearts. (A) 
In situ hybridization (ISH), (B-E) Immunohistochemistry (IHC). High magnification panels show details of 
the left ventricle (lv) at E9.5. (A) Mib1 is expressed at E9.5 in the two tissues of the heart, endocardium 
(arrowhead) and myocardium (arrow). The same expression pattern can be observed at E11.5. (B) Dll4 
is expressed in the endocardium at E9.5 and E11.5 (arrowheads). (C) Jagged1 is expressed only in the 
myocardium at E9.5 and E11.5 (arrowheads). (D) Notch signalling occurs in the base of the trabeculae 
at E9.5 (arrowheads), there is no N1ICD at the top of the trabeculae at E9.5 (arrow), but the pattern is 
expanded to the whole trabecular endocardium at E11.5. (E) Upon deletion of Mib1 in the endocardium 
with Tie2-Cre, in the myocardium with cTnT-Cre or in both with Nkx2.5-Cre Notch signalling is severely 
reduced in the heart (arrowheads). avc, atrio ventricular canal; lv, left ventricle. Scale bar = 200um.
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Mib1 deletion in the 
endocardium and vascular 
endothelium reveals its crucial 
role for Notch in cardiac 
development
Targeted inactivation of Mib1 in the 
endocardium and vascular endothelium with 
the Tie2-Cre driver line (Kisanuki et al., 2001b) 
causes lethality at E10.5. General development 
is delayed and pericardial distension, symptom 
of cardiac malfunction, can be observed (Fig. 
7 A). Histological sections of these embryos 
at E9.5 show that EMT does not occur, only 
a few cells are able to transform and invade 
the endocardial cushions, and trabeculation 
is reduced (Fig. 7 B). This phenotype is 
reminiscent of those observed in Notch1 or 
RBPjK mutants (Timmerman et al., 2004). 
Immunohistochemical analysis of N1ICD 
expression revealed a reduction in Notch 
signalling pathway in the endocardium (Fig. 6). 
The relative expression of Notch target genes 
Hey1, Hey2 and Hey3 was also reduced in 
Mib1flox;Tie2-Cre mutant mice hearts (Fig. 7 C)
In situ hybridization analysis indicated 
that similarly to the phenotype of Notch1 and 
RBPJk mutant mice, the expression of the 
cardiac markers Snail 1 (Fig. 8 A, D), Nrg1 
(Fig. 8 B, D) and Bmp10 (Fig. 8 C, D) was 
severely affected in E9.5 Mib1flox;Tie2-Cre 
embryos.
Analysis of BrdU incorporation (Fig. 9) 
Figure 7. Mib1 inactivation in 
the endocardium and vascular 
endothelium causes a lethal cardiac 
phenotype.
(A) Whole mount comparison of a wild-
type (WT) embryo and a Mib1flox;Tie2-Cre at 
E9.5. Delayed development, impaired heart 
looping and distended pericardium can be 
observed (arrowheads). Scale bar=500um 
(B) Transverse sections of WT and 
Mib1flox;Tie2-Cre at E9.5, trabeculation and 
endocardial cushion formation is blocked 
in transgenic mice (arrowheads). Scale 
bar=200um. (C) Expression of Notch target 
genes, Hey1, Hey2 and Hey3, is reduced 
in the heart by RT-PCR. a, atrium; avc, 
atrioventricular canal; v, ventricle.
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revealed decreased proliferation in the 
myocardium of the ventricle but not in the 
endocardium of the mutant mice.
The results obtained with Mib1flox;Tie2-
Cre mice show mice that Mib1 is a crucial 
modulator of the pathway indispensable for 
early heart development. Dll4, is the Notch 
ligand expressed in the endocardium, would 
direct the early steps of heart development. 
This suggests that the endocardium is the 
tissue driving heart development and that 
the myocardium responds to the signals that 
emanate from the endocardium. 
Figure 8. Tie2-Cre-mediated Mib1 inactivation disrupts valvulogenesis and trabeculation.
 (A-C) In situ hybridization in transverse sections of wild-type (WT) and Mib1flox;Tie2-Cre at E9.5 
showing a reduced expression of trabeculation and valvulogenesis markers in the transgenic mice. Scale 
bar=200um. (D) Semi-quantitative RT-PCR. (A) Snail1 expression is reduced in the AVC (arrowheads). 
(B) Nrg1 expression is reduced in the endocardium of the chambers (arrowheads). (C) Bmp10 expression 
is reduced in the trabecular myocardium (arrowheads). (D) Expression reduction of Snail1, Nrg1 and 
Bmp10 by RT-PCR. a, atrium; avc, atrioventricular canal; v, ventricle.
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Mib1 deletion in the heart 
causes dysmorphic OFT valves
Mib1flox;Tie2-Cre mice had defects in the 
initial steps of valve formation, as EMT is 
almost abolished and only a few cells are able 
to transform and invade the cardiac jelly. These 
few cells express Snail1 (Fig. 8 A, D). To study 
the events that take place after EMT during 
valve development, we bred the Mib1flox mice 
with mice expressing Cre under the control of 
the Nkx2.5 promoter (Stanley et al., 2002). 
Deleting Mib1 in both endocardium and 
myocardium with the Nkx2.5-Cre line causes a 
perinatal lethal cardiac phenotype. Only after 
birth we stop scoring living mutant mice but 
until then the percentages are maintained with 
the expected ranges (Table 1). The difference 
with the Tie2-Cre deletion may be due to 
the expression of this driver in the vascular 
endothelium, where Notch plays an important 
role in early development. On the contrary 
Nkx2.5-Cre is a heart-specific driver.
Analysis of histological sections of 
Mib1flox;Nkx2.5-Cre hearts and their 3D 
episcopic reconstructions (Mohun and 
Weninger, 2011) showed that the transgenic 
mice present a dilated ventricle with thin 
Figure 9. The early ventricular phenotype is due to a reduction of myocardial 
proliferation.
 Transverse sections of wild-type (WT) and Mib1flox;Tie2-Cre at  E9.5. There is a reduction of cellular 
proliferation in the myocardium of the ventricle as shown by immunostaining of incorporated BrdU after 
a 1-h pulse at E9.5, with details of the left ventricle shown (top). Arrowheads indicate BrdU-positive 
nuclei. The ratios of BrdU-positive to total nuclei (bottom) reveal significantly reduced proliferation in the 
myocardium of Mib1flox;Tie2-Cre hearts. n = 3 embryos per genotype. *P < 0.05 by Student’s t test. Data 
are the means ± s.e.m. Scale bar=200um. lv, left ventricle.
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compact myocardium, defects in the integrity 
of the interventricular septum and very 
large trabeculae protruding into the light of 
the chamber (Fig. 10 A, B). The ventricular 
phenotype caused by the deletion of Mib1 
in the myocardium will be described later on 
Mib1flox;cTnT-Cre mice, that are viable and 
recapitulate the same ventricular phenotype 
observed in Mib1flox;Nkx2.5-Cre mice.
Due to the deletion of Mib1 also in the 
endocardium we observed another feature 
in the heart that was not present in the 
Mib1flox;cTnT-Cre mice. Mib1flox;Nkx2.5-Cre 
show large leaflets in the two valves of the OFT, 
the aortic valve (Fig 10 C) and the pulmonary 
valve (Fig.10 D). After the histological 
analysis of the valves we performed a 3D 
reconstruction with Amira software where we 
could observe that the leaflets of the mutant 
mice are misaligned forming and aberrant and 
dysmorphic valve (Fig 10 C). 
Deletion of Mib1 in the endocardium and 
myocardium but specifically in the SHF 
using Islet1-Cre (Cai et al., 2003) reveals a 
specific phenotype in SHF derivatives, the 
right ventricle and the valves of the OFT (Fig. 
11). Although trabeculation and compaction 
occurred normally in the left ventricle, 
compact myocardium is thinner and there 
are less trabeculae in the right ventricle of 
Mib1flox;Isl1-Cre mice (Fig. 11 A). Leaflets of 
the aortic valve are enlarged and the valve 
is dysmorphic similarly to Mib1flox;Nkx2.5-Cre 
hearts (Fig. 11 B). 
The consequences of MIb1 inactivation on 
ventricular and valvular development is most 
likely what causes Mib1flox;Nkx2.5-Cre death 
at perinatal stages. 
Migrating neural crest is 
present in Mib1flox;Nkx2.5-Cre 
mice
Neural crest is crucial for valve cushion 
formation and septation of the OFT (Kirby et al., 
1983, Jiang et al., 2000). It has been described 
in DNMAML;Isl1-Cre mice that the absence 
of the neural crest-derived mesenchymal 
cells produces enlarged OFT leaflets similar 
to those observed in the Mib1flox;Nkx2.5-Cre 
mice (High et al., 2009, Jain et al., 2011). 
Mib1flox/flox;
Nkx2.5-Cre/+
Mib1flox/+;
+/+
Mib1flox/+;
Nkx2.5-Cre/+
Mib1flox/flox;
+/+
E9.5 56 15 (26.78%) 17 (30.35%) 12 (21.42%) 12 (21.42%)
E10.5 44 4 (9.09%) 9 (20.45%) 11 (25%) 20 (45.45%)
E11.5 99 26 (26.26%) 32 (32.32%) 23 (23.23%) 18 (18.18%)
E12.5 40 7 (17.5%) 5 (12.5%) 16 (40%) 12 (30%)
E14.5 58 16 (27.58%) 12 (20.68%) 15 (25.86%) 15 (25.86%)
E15.5 285 62 (21.75%) 81 (28.42%) 70 (24.56%) 71 (25.26%)
E16.5 124 25 (20.16%) 39 (31.45%) 28 (22.58%) 32 (25.80%)
E17.5 34 8 (23.52%) 7 (20.58%) 8 (23.52%) 11 (32.35%)
P3 36 0 (0%) 14 (38.88%) 13 (36.11%) 9 (25%)
TOTAL 742 155 (20.88%) 209 (28.16%) 188 (25.33%) 190 (25.60%)
Expected 25% 25% 25% 25%
# embryos dissected (percentage observed)
Table 1. Mib1flox;Nkx2.5-Cre lethality table
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Figure 10. Inactivation of Mib1 in the endocardium and myocardium with the Nkx2.5-Cre 
line produces dysmorphic OFT valves.
(A, C, D) Transverse sections of wild-type (WT) and Mib1flox;Nkx2.5-Cre at E16.5, (A) showing the 
ventricles and (C top, D) details of aortic and pulmonary valve.  (B) 3D episcopic reconstruction of the 
hearts in (A). (C bottom) 3D reconstruction of the transverse sections in (C top). (A, B) Mib1flox;Nkx2.5-
Cre heart is dilated, presents prominent trabeculae in the light of the ventricles, the compact area 
of the ventricular wall is thinner and show a ventricular septum defect (asterisk). (C, D) aortic and 
pulmonary valve leaflets are enlarged (arrowheads) and misaligned as shown by the 3D reconstruction 
in Mib1flox;Nkx2.5-Cre mice. Scale bar=200um. rv, right ventricle; lv, left ventricle; ra, right atrium; la, left 
atrium; aov, aortic valve.
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These mice show a reduction of apoptosis 
at the time of valve morphogenesis and 
septation resulting in enlarged leaflets (Jain et 
al., 2011). Notch plays an important role in the 
migration of neural crest cells into the heart 
(High et al., 2007, High et al., 2009) thus we 
assayed the presence of the migrating neural 
crest in the OFT of Mib1flox;Nkx2.5-Cre mice 
(Fig. 12). Expression of neural crest markers 
PlexinA2 (Fig.12 A), Sema3C (Fig. 12 B) and 
AP2a (Fig. 12 C) is present in the endocardial 
cushions of the OFT of Mib1flox;Nkx2.5-Cre 
mice at E11.5, indicating that the neural crest 
has migrated into the developing cushions of 
the OFT, and therefore it is not the cause of 
the dysmorphic OFT valves.
Notch regulates BMP 
signalling during valve 
morphogenesis
Bmp6 and Bmp7 are expressed in the OFT 
leaflets and are necessary for their formation 
(Kim et al., 2001). For this reason we 
analysed the expression of BMP molecules 
in the maturating OFT (Fig. 13). By in situ 
hybridization we can observe an up-regulation 
of Bmp6 in the mesenchyme of the aortic valve 
(Fig. 13 A) and a down-regulation of Smad6, 
a negative regulator of the BMP signalling 
pathway (Fig. 13 B). To assess the activation 
of BMP signalling we used an antibody specific 
for the phosphorylated proteins Smad1/5/8. 
Phosphorylation of SMAD proteins is a read-
out of BMP signalling activation (Massague 
et al., 2005, van Dijk et al., 2012) and in 
the dysmorphic valves of Mib1flox;Nkx2.5-
Figure 11. Deletion of Mib1 in the specifically in the SHF produces dysmorphic OFT 
valves.
(A, B) Transverse sections of wild-type (WT) and Mib1flox;Isl1-Cre at E16.5, (A) showing the ventricles 
and (B) details of aortic valve. (A) Mib1flox;Isl1-Cre heart shows abnormal trabeculation in the right ventricle 
(arrowheads). (B) aortic and pulmonary valve leaflets are enlarged (arrowheads) and misaligned. The 
phenoptype observed in the valves is very similar to that observed in Mib1flox;Nkx2.5-Cre mice. Scale 
bar=200um. rv, right ventricle; lv, left ventricle; ra, right atrium.
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Cre we observe an increased P-Smad1/5/8 
expression in the mesenchyme of the valves 
(Fig. 13 C). The increase of mesenchymal 
phosphorylated SMADs confirms the excess 
of BMP signalling in the Mib1flox;Nkx2.5-Cre 
valves.
The increased BMP signalling activity 
together with the large valve leaflets observed 
suggested affected cellular proliferation in 
Mib1flox;Nkx2.5-Cre mice. BMP signalling 
has been related to proliferation during heart 
development (Chen et al., 2004). Analysis 
of BrdU incorporation in the valves revealed 
and increased proliferation rate (10%) of 
the mesenchymal cells in the leaflets of 
Mib1flox;Nkx2.5-Cre mice (Fig. 13 D). The 
larger size of the OFT leaflets is probably 
due to the increased in mesenchyme cellular 
proliferation. This larger leaflet size is most 
likely the reason why they appear misaligned, 
as they do not fit in the aortic ring.
Notch is active in the endocardium of the 
maturing OFT valves (Del Monte et al., 2007), 
but the increased proliferation caused by 
the up-regulation of BMP signalling occurs 
in the mesenchyme, suggesting that MIb1 
inactivation may exert a non-cell autonomous 
effect in valve mesenchyme.
Together, these results suggest that Notch 
is crucial for the maturation of OFT valves. 
Figure 12. Neural crest is not responsible for the dysmorphic valve phenotype.
(A-C) Transverse sections of wild-type (WT) and Mib1flox;Nkx2.5-Cre at E11.5 hearts showing details 
of the OFT. (A,B) In situ hybridization. (C) Immunohistochemistry. Post migratory neural crest is present 
in Mib1flox;Nkx2.5-Cre mice as shown by staining of different neural crest markers (arrowheads); (A) 
PlexinA2, (B) Sema3C and (C) AP2a. Scale bar=200um. oft, outflow tract; rv, right ventricle; lv, left 
ventricle. 
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Figure 13. Mib1 inactivation produces a BMP signalling deregulation and increased 
cellular proliferation.
(A-D) Transverse sections of wild-type (WT) and Mib1flox;Nkx2.5-Cre hearts showing details of aortic 
valve. (A, B) In situ hybridization. (C, D) Immunohistochemistry. BMP signalling is up-regulated in 
Mib1flox;Nkx2.5-Cre. (A) Bmp6 is up-regulated (arrowheads). (B) Smad6, a negative regulator, down-
regulated (arrowheads). (C) Phosphorylation of SMAD proteins 1, 5 and 8, readout of BMP up-regulation, 
is increased (arrowheads). (D) There is a reduction of cellular proliferation in the mesenchyme of the 
valve leaflet as shown by immunostaining of incorporated BrdU after a 1-h pulse at E15.5, with details 
of the aortic valve shown (top). Arrowheads indicate BrdU-positive nuclei. The ratios of BrdU-positive to 
total nuclei (bottom) reveal significantly reduced proliferation in the mesenchyme of Mib1flox;Nkx2.5-Cre 
OFT valves. n = 3 embryos per genotype. *P < 0.05 by Student’s t test. Data are the means ± s.e.m. 
Scale bar=200um.
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Once the endocardial cushions have been 
formed and they need to be remodelled, 
Notch regulates BMP signalling and cellular 
proliferation in a non-cell autonomous fashion. 
Jag1 and Dll4 are expressed in the 
endocardium of the OFT. Deleting Mib1 with 
the Nkx2.5-Cre driver disrupts signalling of 
both ligands, so we cannot discard that Dll4 has 
a role to play after EMT in valve development. 
In the case of the dysmorphic OFT valves, we 
cannot dissect if the phenotype is caused by 
the abrogation of the signal by Dll4 or Jag1 
or if both ligands are important for valve 
maturation. 
Mib1 deletion in the 
myocardium causes LVNC
To determine the role of the ligand (-s) 
signalling from the myocardium, Mib1 was 
deleted in in the myocardium with the cTnT-
Cre line (Jiao et al., 2003). The ligand 
expressed in the myocardium is Jag1 (Fig. 
6 C). Mib1-mediated genetic inactivation of 
the myocardial signal produces a reduction 
of Notch1 activation in the endocardium (Fig. 
6 E). Mib1flox;cTnT-Cre mice are viable but 
show a striking embryonic foetal phenotype 
(Fig. 14). Although these mice are viable there 
is a reduction of survival after E15.5 when 
the observed mutant percentage goes from 
around 25% to only around 14% after birth 
(Table 2).
The histological examination and 3D 
episcopic reconstruction (Mohun and 
Weninger, 2011) of the histological sections 
at E16.5 showed that mutants have a dilated 
heart with thin compact myocardium and 
large, non-compacted trabeculae protruding 
toward the light of the ventricle and defects 
in the ventricular septum (Fig. 14 A-D). 
The same features can be observed in 
newborn mice. WT newborn mice show an 
already well compacted myocardium while 
the Mib1flox;cTnT-Cre littermates have large 
trabeculae in the left and right ventricles. The 
defects in the septum can still be observed 
and fibrotic areas are present around those 
defects (Fig. 14 D). These mice show the same 
ventricular phenotype as the Mib1flox;Nkx2.5-
Cre (Fig 10). In the case of the Mib1flox;cTnT-
Cre, only myocardial ligand signalling is 
compromised and thus, there is no OFT 
phenotype and mutant mice are viable and 
reach adulthood, allowing us to study the Mib1 
Mib1flox/flox;
cTnT-Cre/+
Mib1flox/+;
+/+
Mib1flox/+;
cTnT-Cre/+
Mib1flox/flox;
+/+
E9.5 58 16 (27.58%) 13 (22.41%) 16 (27.58%) 13 (22.41%)
E10.5 71 20 (28.16%) 16 (22.53%) 19 (26.76%) 16 (22.53%)
E11.5 193 43 (22.27%) 57 (29.53%) 46 (23.83%) 47 (25.35%)
E13.5 67 11 (16.41%) 19 (28.35%) 19 (28.35%) 18 (26.86%)
E14.5 93 20 (21.50%) 22 (23.65%) 24 (25.80%) 27 (29.03%)
E15.5 168 43 (25.59%) 42 (25%) 47 (27.97%) 36 (21.42%)
E16.5 115 22 (19.13%) 24 (20.86%) 41 (35.65%) 28 (24.34%)
P3 48 7 (14.58%) 15 (31.25%) 12 (25%) 14 (29.16%)
TOTAL 813 182 (22.38%) 208 (25.58%) 224 (27.55%) 199 (24.47%)
Expected 25% 25% 25% 25%
# embryos dissected (percentage observed)
Table 2. Mib1flox;cTnT-Cre lethality table
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ventricular phenotype. The non-compaction 
phenotype observed during development in 
the embryo and after birth in the newborn is 
maintained and can be observed later in adult 
mice. 
Echocardiographic analysis of adult mice 
revealed prominent trabeculations and deep 
intertrabecular recesses in the mutants (Fig. 
15 A and Videos 1 and 2. ep, epicardium; en, 
endocardium, prominent trabecules marked 
with asterisk). Measuring the ratio of non-
compacted myocardium and compacted 
myocardium revealed that the mutant mice 
had a non-compaction index of 2.0 (Fig. 15 B). 
A non-compaction index equal or larger than 
2.0 is a diagnostic landmark for LVNC (Jenni et 
al., 2001, Stollberger et al., 2002). In addition 
to all the structural defects mentioned above, 
Figure 14. Mib1 inactivation in the myocardium produces LVNC.
Transverse sections of wild-type (WT) and Mib1flox;cTnT-Cre hearts. (A) Sections at E16.5. Mib1flox;cTnT-
Cre mutant heart is dilated, has large trabeculae, the compact myocardium is thinner than in the WT and 
presents abnormal ventricular septum (asterisk). (B) Scheme showing the plane of histological sections 
in (A, D). (C) Episcopic 3D reconstruction of (A) where the abnormal septum (asterisk) and the very thin 
compact wall (arrowhead) are very evident. (D) Heart sections from P3 mice. The myocardium in WT 
mice is almost fully compacted (D, enlarged in E, arrowheads); in contrast, hearts from Mib1flox;cTnT-
Cre mutants have very large trabeculae (D, enlarged in F, arrowheads). Asterisks indicate abnormal 
ventricular septum in the mutants. Scale bar=200um. ra, right atrium; la, left atrium; rv, right ventricle; lv, 
left ventricle.
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Mib1flox;cTnT-Cre mice have a significantly 
reduced systolic function measured here by 
ejection fraction (Fig. 15 B). To better define 
this phenotype in adults we performed high-
resolution Cardiac Magnetic Resonance 
Imaging (CMRI) on adult mice, which revealed 
the presence of large, non-compacted 
trabeculae in the light of the ventricles of adult 
mutant mice (Fig. 15 C, D). To study in more 
detail the phenotype details of the ventricular 
wall we studied the adult hearts with scanning 
electron microscopy (SEM) and we observed 
how the big coronary veins present in the most 
external part of the compact myocardium are 
very close to the light of the chamber due to 
this trabecular recesses. Large trabeculae 
invading the lumen of the ventricle are also 
present in the mutant hearts (Fig. 15 E-J).
Our results indicated that myocardial 
inactivation of Mib1 caused a late chamber 
phenotype in which cardiac maturation was 
defective. Jag1 is a ligand expressed in the 
Figure 15. Adult mice LVNC phenotype.
(A) Echocardiography analysis in 6-month-old wild-type (WT) and Mib1flox;cTnT-Cre mice. Arrowheads 
indicate the smooth endocardial surface in the WT heart. Note the thickened and irregular endocardial 
layer in the mutant heart. Scale bar, 1 mm. (B) Non-compaction index and ejection fraction in hearts of 
6-month-old WT and Mib1flox;cTnT-Cre mice. *P < 0.05 determined by Student’s t test. Data are the mean 
± s.e.m. (C,D) CMRI in 6- onth-old WT and Mib1flox;cTnT-Cre mutant mice. Images show four-chamber 
(4c) and short axis (sa) views. Scale bars, 1 mm. Arrowheads indicate the smooth ventricular surface 
(C) or prominent trabeculae in ventricular lumens (D). (E-J) Scanning electron microscopy of 6-month-
old WT and Mib1flox;cTnT-Cre hearts showing details of right ventricle (F, I) and left ventricle (G, J). 
Arrowheads show the trabeculae in the chamber (I, J) and the compacted myocardium (G) compared to 
the deep intertrabecular recesses in mutant hearts (J). rv, right ventricle; lv, left ventricle; r , right atrium; 
la, left atrium.
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myocardium at these stages, suggesting that 
the Mib1 phenotype was due, at least in part, 
to impaired Jag1-dependent signalling. 
The structural and functional features 
observed in the Mib1flox;cTnT-Cre hearts 
reproduce the features associated  to the 
human LVNC cardiomyopathy, suggesting 
that Mib1flox;cTnT-Cre may be a mouse model 
to study this disease.
Human MIB1 mutations cause 
LVNC
We next examined whether mutations 
in human MIB1 are associated with clinical 
LVNC. Sequencing of the 20 coding exons of 
MIB1 in a cohort of 100 individuals of Southern 
European ancestry (Spanish) with LVNC 
identified two mutations. The two mutations 
were found in familial cases of LVNC; in this 
study 48% of the LVNC cases analysed were 
familial. 
One mutation identified in a proband 
with inherited LVNC is a heterozygous G>T 
transversion of nucleotide 2827 in exon 20 
of MIB1, which predicts a change in amino 
acid 943 from valine to phenylalanine (V943F, 
present in proband 1.III.1; Fig. 16 A-E). 
Val943 is located within a coiled-coil region 
separating the three ring-finger domains 
that mediate protein-protein interactions and 
comprise the site of MIB1 ubiquitin ligase 
activity (Barsi et al., 2005) (Fig. 16 A) In silico 
modelling with PolyPhen-2 (Adzhubei et al., 
2010) of the effect of the V943F mutation on 
MIB1 structure and function gave out a score 
of 0.675. This means that the mutation of this 
residue in the protein would have a potentially 
deleterious effect. In silico reconstruction of 
the MIB1 protein structure suggested that the 
phenylalanine aromatic ring could disrupt the 
tertiary structure of the ring-finger region (Fig. 
16 C). Phylogenetic analysis (Fig. 16 D) and 
the high genetic evolutionary rate profiling 
(GERP) score (Davydov et al., 2010) of Val943 
(5.67) indicated that this amino acid is under 
selective constraint.
Genotyping of other family members of 
the proband tracked the mutation back three 
generations (Fig. 16 E) and showed that it 
occurred only in LVNC-affected individuals 
within the family. 
The second mutation that we identified is 
a heterozygous C>T transition of nucleotide 
1587 in MIB1 exon 11, which predicts a 
premature stop codon instead of arginine at 
position 530 in the MIB1 ankyrin repeats region 
(R530X, present in proband 2.II.1; Fig. 16 A, F, 
G). We tracked this mutation back through two 
generations of LVNC-affected individuals (Fig. 
16 G).
The inheritance pattern observed in both 
families was autosomal dominant and the 
disease phenotype was highly penetrant being 
present in all the members of the families that 
carried the mutation. 
After comparing all the individuals carrying 
either one or the other mutation and with LVNC 
to a cohort of healthy volunteers (Table 3) we 
observed that there is a perfect correlation 
of genotype and phenotype. All the patients 
carrying MIB1 mutations fulfilled at least one 
the criteria to diagnose LVNC. It is interesting 
to note that there are no differences in these 
families related to sex or age of the patients.
To rule out the presence of other mutations 
in the patients we analysed the DNA of the 
two families and sequenced MHY7, MYBPC3, 
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Figure 16. Mutations in human MIB1 cause LVNC.
(A) Schematic of MIB1 domain structure. A valine-to-phenylalanine missense mutation (V943F) is 
located in the ring-fingers domain of MIB1 and was found in one patient with LVNC from family 1 (open 
circle). A premature stop codon mutation (R530X) is located in the ankyrin repeats region and was found 
in another affected family, family 2 (asterisk). (B) Sequence chromatogram of unaffected and affected 
members of family 1. Val, valine; Phe, phenylalanine. (C) In silico model of the MIB1 monomer; color 
code as in (A). The aromatic ring of the phenylalanine residue (yellow, arrow) probably affects the tertiary 
structure of this domain. (D) Evolutionary conservation of Val943. (E) Occurrence of the V943F mutation 
and LVNC in family 1 over three generations. Members of each generation are indicated numerically; 
squares, males; circles, females. The proband is indicated by an arrow. (F) Sequence chromatograms of 
unaffected and affected members of family 2 showing the position of the R530X mutation. (G) Occurrence 
of R530X and LVNC in family 2 over two generations.
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TNNT2, TNNI3, TPM1, ACTC, MYL2, MYL3, 
TNNC, G4.5, LDB3 and LMNA, candidate 
genes implicated in LVNC (Captur and 
Nihoyannopoulos, 2010, Ichida, 2009) and no 
mutation was found in any of the two families. 
As a control a group of 263 healthy individuals 
from Spain was sequenced and none 
presented any of the two mutations indicating 
that they were not common single nucleotide 
polymorphisms (SNPs). The fact that the 
mutations are not SNPs and that the families 
only present one gene mutated indicates that 
this two MIB1 de novo mutations are the cause 
for the LVNC in these patients.
Human LVNC phenotype 
associated to MIB1 mutations
The proband with the V943F mutation 
(1.III.1) underwent heart transplantation, and 
pathological examination of her heart revealed 
evident signs of LVNC. The persistent 
trabeculation is obvious in the two ventricles 
especially in the left ventricle where the non-
compacted layer is almost as thick as the 
compacted one (Fig. 17 A).
Four- and two-chamber CMRI views of 
the hearts of the fathers of the two probands 
(1.II.3 and 2.I.2; Table 3) revealed prominent 
trabeculations that were not present in the heart 
of an unaffected subject (Fig. 17 B and Videos 
7–12). The short-axis views revealed marked 
trabeculations in the right ventricles as well 
(Fig. 17 B and Supplementary Videos 13–15) 
consistent with the histopathological analysis 
of the heart of the transplanted individual. The 
phenotype observed in the human patients of 
LVNC is similar to the phenotype that we have 
observed in the Mib1flox; cTnT-Cre mice (Fig. 
14, 15).
Western blot analysis of peripheral 
blood from patients 1.II.3 and 2.I.2 revealed 
approximately 8% and 20% reductions, 
respectively, in MIB1 expression compared 
to control samples (Fig. 17 C. D). We did not 
detect the predicted truncated MIB1 form 
generated by the R530X mutation (Fig. 16 
D) suggesting that the mutant mRNA might 
be degraded by nonsense-mediated decay 
(NMD) (Frischmeyer et al., 2002). 
We next analysed N1ICD expression in 
Figure 17. LVNC patients with MIB1 mutations have reduced expression of N1ICD, DTX1 
and GATA3.
(A) Sections of a structurally normal heart and the heart of the proband from family 1 (1.III.1; Fig. 15), 
who has the V943F mutation. Arrowheads indicate the compacted myocardium in the control heart and 
the non-compacted myocardium in the proband’s heart. Scale bars, 10 mm. Rv, right ventricle; lv, left 
ventricle. (B) CMRI sections of hearts showing four-chamber (4c), two-chamber (2c) and short axis (sa) 
views comparing images of a control heart (in an individual without the MIB1 mutation) with images of the 
heart of subject 1.II.3, who has the V943F MIB1 mutation, and images of the heart of subject 2.I.2, who 
has the R530X MIB1 mutation. Arrowheads indicate the trabeculae, which are prominent in the ventricles 
of the individuals with MIB1 mutations. Scale bars, 50 mm. (C–E) Western blots of MIB1 and N1ICD in 
lymphocytes from the blood of three healthy donors (C1–C3) and subjects 1.I.2, 1.II.3, 1.III.2, 2.I.4, 2.II.1 
and 2.I.7. Densitometric quantification of the protein expression shows low MIB1 expression (C,D) and 
a parallel reduction in NOTCH activity (E,F). Data are the mean ± s.e.m. (G) Quantitative real-time RT-
PCR analysis of the expression of DTX1 and GATA3 expression relative to that of GUSB in the subjects 
analyzed in (E). *P < 0.05 determined by Student’s t test. Data are the mean ± s.e.m.
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peripheral blood samples from groups of 
three patients carrying the V943F mutation 
(1.I.2, 1.II.2 and 1.III.2) or the R530X mutation 
(2.I.4, 2.II.1 and 2.I.7). Both groups showed a 
significant reduction of about 50% of N1ICD 
expression compared with unaffected subjects 
(Fig. 17 E, F). We also analysed white blood 
cells from these patients for the expression 
of NOTCH targets specific for developing 
human T lymphocytes: DTX1, GATA3, HES1, 
NOTCH3, NRARP, TCF7, HEY1 and c-MYC 
(Van de Walle et al., 2009). The expression of 
DTX1 and GATA3 was lower in both groups 
of patients compared with unaffected subjects 
(Fig. 17 G) Together these data indicate that 
both of the MIB1 mutations affect NOTCH 
signalling. 
To further investigate the effect of the 
mutations on MIB1 expression and what 
happens with the truncated mRNA, we 
synthesized cDNA from the peripheral blood 
of patients 1.I.2, 1.II.3 and 1.III.2 (all with 
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V943F), patients 2.I.4, 2.II.1 and 2.I.7 (all with 
R530X) and control samples and performed 
quantitative real-time PCR (qPCR) using two 
primer pairs targeting regions 5′and 3′ to the 
mutation sites (Fig. 18 A). This is a common 
strategy used to determine the stability of 
mRNAs carrying premature stop codons. In 
the case of the V943F mutation, the two primer 
pairs did not detect statistically significant 
differences in expression of 3’ and 5’ PCRs 
compared to control MIB1 cDNA (Fig. 17 A-C). 
In contrast, in the case of the R530X mutation, 
the 3′ primers detected significantly lower 
mRNA expression (Fig. 18 A, D, E) suggesting 
that a nonsense mediated decay (NMD) 
mechanism might be responsible for degrading 
R530X mutant mRNA. NMD is a surveillance 
pathway which function is to reduce errors in 
gene expression by eliminating mRNA with 
premature stop codons (Chang et al., 2007). 
We next amplified the cDNA regions spanning 
both mutations by RT-PCR and cloned the 
Table 3. Features of LVNC patients harbouring MIB1 mutations
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266-bp (V943F) and 433-bp (R530X) PCR 
products en masse and sequenced them. 
Whereas V943F mutant and WT cDNAs 
were cloned at similar frequencies, the cDNA 
containing the R530X mutation was never 
amplified (Fig. 18 A, F-G). These confirm our 
hypothesis that the truncated mRNA resulting 
from the R530X allele is degraded by NMD. 
Figure 18. Effect of p.Val943Phe and p.Arg530X mutations on MIB1 mRNA expression.
 (A) Scheme of MIB1 cDNA. PCR-amplified exons are numbered. The arrows indicate the PCR 
primers, green colouring the regions amplified by qPCR, and red the regions spanning the MIB1 mutations 
(*) that were amplified by RT-PCR, cloned and sequenced. (B-E) qPCR analysis of lymphocytes from 
three control subjects and three patients. (B,C) The 5’ and 3’ regions of the MIB1 cDNA are amplified 
at similar levels in control and patient samples, suggesting that the p.Val943Phe mutation does not 
significantly affect MIB1 transcription. (D,E) In patients with the p.Arg530X mutation, the 5’ region of 
MIB1 is expressed at normal levels (D) but the 3’ region is not (E), suggesting that the mRNA is being 
degraded. (F,G) Sequence chromatogram of the PCR fragments spanning the p.Val943Phe mutation. 
54.17% (13 out of 24) of the clones analyzed contained a wild-type (WT) G nucleotide (F) and 45.83% 
(11 out of 24) a T (G), suggesting that the mutant and WT mRNA are expressed at similar levels. (H) 
Sequence chromatogram of the PCR fragments spanning the p.Arg530X mutation. Only the WT gene 
was amplified (100%).
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Identified mutations disrupt 
MIB1 and NOTCH activity
In silico modelling supports the idea 
that MIB1 is a homodimer (Fig. 19 A). This 
modelling also indicated that the V943F 
mutant would alter the alignment of the ring-
finger domains in heterodimers formed by 
WT and V943F mutant MIB1 (Fig. 19 B). The 
dimerization would happen anti-pairwise and 
situate the active domain of the monomers, 
responsible for the ubiquitylation of Notch 
ligands, close to each other. Furthermore, 
modelling of the docking of the MIB1-dimer 
ring fingers with JAG1 indicates that formation 
of V943F-WT dimers would distort the angle of 
interaction with JAG1 and thus interfere with 
the signalling (Fig. 19 C-F).
To test whether MIB1 forms a homodimer, 
we carried out co-immunoprecipitation (coIP) 
assays with hemagglutinin (HA)-tagged 
WT MIB1 and various Flag-tagged MIB1 
variants: WT, V943F, R530X and a previously 
characterized dominant-negative mutant 
(M989R) (Zhang et al., 2007b). We co-
transfected these tagged cDNAs in pair-wise 
combinations with the HA-tagged WT MIB1 
cDNA into HEK293 cells. Immunoprecipitation 
with antibodies to Flag and western blotting 
with antibodies to HA detected a 100-kDa 
band corresponding to WT MIB1 in all 
immunoprecipitates, and western blotting with 
an antibody to Flag confirmed the presence of 
all Flag-tagged MIB1 variants, even the short 
form corresponding to the R530X mutation 
(Fig. 20 A). These results indicate that MIB1 
forms homodimers and even the mutant 
forms are able to interact. Interaction between 
the monomers probably occurs through 
ankyrin repeats, as has been established 
for other proteins containing this domain 
(Sedgwick and Smerdon, 1999). Detection 
in the immunoprecipitate of the truncated 
MIB1 protein encoded by the R530X mutant 
cDNA is probably a result of its expression 
from a cDNA construct that does not undergo 
splicing, thereby escaping NMD. We confirmed 
these findings by fluorescence resonance 
energy transfer (FRET) using the acceptor 
photobleaching technique (Rodighiero et al., 
2008).
Similarly to the co-IP experiments, we 
co-transfected HEK293 cells in pairwise 
combinations with the pEYFP-C1 plasmid 
encoding yellow fluorescent protein (YFP)-
tagged WT MIB1 and the pECFP-C1 plasmid 
encoding cyan fluorescent protein (CFP)-
tagged WT MIB1 or V943F or R530X mutant 
MIB1. We found that both MIB1 mutant proteins 
interacted with the WT protein (Fig. 21). We 
then transfected the various Flag-tagged 
mutant MIB1 variants into HEK293 cells stably 
expressing murine Jag1 (Chapman et al., 
2006) and carried out coIP assays. Western 
blot analysis with antibodies to JAG1 detected 
this protein in immunoprecipitates of all 
mutant variants (V943F, R530X and M989R) 
using antibodies to Flag (Fig. 20 B). The MIB1 
heterodimers are able to bind normally to 
the Notch ligands and thus interfere with the 
normal signalling.
Then we tested the effect of the MIB1 
mutations on JAG1 ubiquitylation, because 
that is the biochemical function of MIB1 in 
the signalling cells of the pathway. We co-
transfected HEK293 cells with JAG1, eGFP-
tagged ubiquitin (Hansson et al., 2010), WT 
HA-tagged MIB1 and the Flag-tagged MIB1 
variants (V943F, R530X or M989R). JAG1 
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ubiquitylation was strongly induced in cells 
transfected with WT MIB1 plus empty vector, 
but was markedly lower in cells co-transfected 
with WT MIB1 plus V934F or WT MIB1 plus 
the R530X mutant (Fig. 20 C). Thus, in this 
setting, the V934F and R530X mutants seem 
to impair MIB1 function in a dominant-negative 
fashion. Co-transfection of WT MIB1 and the 
M989R mutant cDNA yielded similarly low 
amounts of JAG1 ubiquitylation as the other 
mutations (Fig. 20 C).
To study the effect of these mutant MIB1 
variants in vivo, we microinjected the mutant 
mRNAs into Tg(mlc2a:GFP) zebrafish embryos, 
which express eGFP in cardiomyocytes in the 
developing heart. We compared the outcomes 
from these zebrafish with the reference 
Figure 19. In silico modelling predicts that MIB1 functions as a dimer.
(A,B) Theoretical MIB1-MIB1 dimer models predicted with the Hex server. (C-F) JAG1-MIB1 docking 
models predicted with the ClusPro server. All protein structures were predicted with iTASSER. (A) MIB1 
homodimer formed by two WT chains (green and orange). (B) MIB1 heterodimer formed by one WT 
MIB1 chain (green) and one p.Val943Phe MIB1 mutant chain (red). Yellow indicates 943V or 943F. 
The yellow bar indicates relative distance between the MIB/herc2 domains which is greater in the WT-
V943 heterodimer. (C,E) Docking model for JAG1 and WT MIB1 (wheat, JAG1; cyan, MIB1; green, MIB/
herc2 domains; orange, ring finger domains; red, coiled-coil domain; yellow, 943V). (D,F) Docking model 
for JAG1 and p.Val943Phe MIB1, showing a distorted JAG1-MIB1 angle (arrowhead) caused by the 
increased distance between the MIB/herc2 domains of the mutant heterodimer. (Wheat, JAG1; cyan, 
WT MIB1; light cyan p.Val943Phe MIB1; green, MIB/herc2 domains; orange, ring finger domains; red, 
coiled-coil domain; yellow, 943F).
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phenotype of zebrafish homozygous for 
the mib1ta52b allele, equivalent to the 
dominant-negative M989R mutation (Zhang 
et al., 2007b), which show severely defective 
cardiovascular development. Examination of 
larvae at 72 h post fertilization (h.p.f.) injected 
at the one- to two-cell stage with control eGFP 
mRNA revealed normal leftward looping of 
the two-chambered heart and transgene 
expression delineating the ventricle (Fig. 20 
D, E). Development was similarly unaffected 
by microinjection with WT MIB1 mRNA 
(Fig. 20 D, E). In contrast, when injecting 
the different Mib1 variants we observe not 
only a cardiac phenotype but also a general 
developmental phenotype characteristic of 
abrogated Notch signalling. Microinjection 
with V943F mutant mRNA severely disrupted 
embryonic development, impairing cardiac 
looping and generating a kinked tail (Fig. 20 
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D, E). Microinjection of R530X mutant mRNA 
produced a similar phenotype (Fig. 20 D, E) 
as did microinjection of the control M989R 
mutant mRNA (Fig. 20 D, E). The cardiac and 
tail defects in each group were similar to those 
in Tg(mlc2a:GFP); mibta52b/ta52b mutants, which 
also showed a marked pericardial distension 
(Fig. 20 D), suggesting abnormal cardiac 
function. Moreover, microinjection of the 
various MIB1 mutant mRNAs into the zebrafish 
Notch reporter line Tg(Tp1bglob:eGFP)um14 
(Parsons et al., 2009) strongly attenuated 
reporter expression (Fig. 20 F). These data 
indicate that the V943F and R530X MIB1 
mutations severely impair Notch activity in 
vivo.
To complement these findings, we co-
cultured HEK293 cells stably expressing Jag1 
transfected with the various MIB1 variants with 
Notch1-expressing HEK293 cells (Chapman 
et al., 2006) co-transfected with the Notch 
signalling reporter 10xCBF1-Luc (McKenzie et 
al., 2005) and Renilla luciferase. This reporter 
contains ten repetitions of the RBPjK binding 
site in front of the luciferase gene that will 
be expressed upon Notch activation. Jag1-
HEK293 cells expressing WT MIB1 increased 
the activity of the 10xCBF1-Luc reporter, 
whereas the V934F, R530X and M989R 
Figure 20. MIB1 is a homodimer whose ubiquitin ligase activity is impaired by the 
identified mutations.
(A) HA and Flag blotting in Flag immunoprecipitates of HEK293 cells co-transfected with WT HA-
tagged MIB1 (Flag-WT MIB1) and various Flag-tagged MIB1 variants (Flag-M989R, Flag-tagged 
M989R MIB1; Flag-MIB1-VF, Flag-tagged V943F MIB1; Flag-MIB1-STOP, Flag-tagged R530X MIB1). 
IP, immunoprecipitation; WB, western blotting. (B) Flag and Jag1 blotting in Flag immunoprecipitates of 
Jag1-expressing HEK293 cells co-transfected with Flag-tagged WT MIB1 or Flag-tagged MIB1 variants. 
(C) GFP, JAG1, HA, Flag and MIB1 blotting in JAG1 immunoprecipitates of HEK293 cells co-transfected 
with JAG1, ubiquitin-GFP and empty vector (EV) or JAG1, ubiquitin-GFP and HA-tagged WT MIB1 plus 
one of the various forms of Flag-tagged (FG) MIB1 (VF, V943F mutation; ST, R530X mutation; MR, 
M989R mutation) or the empty vector. JAG1 immunoprecipitation was followed by western blotting for 
GFP-tagged ubiquitin to reveal ubiquitination (top). Western blotting with antibodies to HA and Flag 
revealed expression of WT and mutant MIB1 variants (middle). MIB1 western blotting revealed basal 
expression in non-transfected cells and similar expression levels in transfected cells. JAG1 was present 
in all immunoprecipitates (bottom). Actin was used as a loading control (D,E) Effect of MIB1 variant 
mRNAs on zebrafish development. Lateral and ventral views are shown. Left, 72 h.p.f. Tg(mlc2a:eGFP) 
transgenic zebrafish larva microinjected with control GFP mRNA. The heart appears normal and looped 
towards the left (arrowhead). The remaining images show results of microinjection of mRNAs encoding 
WT, V943F, R530X and M989R MIB1. Note the kinked tail and the straight heart tube (arrowheads). 
The mib1ta52b mutant shows a similar phenotype to that of embryos microinjected with mutant forms of 
MIB1. Note also the pericardial dystension (arrow). Scale bars, 0.5 mm. (e) Percentage of larvae with 
a mutant phenotype at 72 h.p.f. after microinjection of the MIB1 mRNAs. (F) Notch reporter expression 
in Tg(Tp1bglob:eGFP)um14 larvae at 30 h.p.f. after microinjection of MIB1 mutant mRNAs. Activity was 
measured by quantification of GFP luminescence. The solid black bar shows basal reporter activity in 
uninjected larvae. AU, arbitrary units. (G) Notch signaling activity measured by 10xCBF1-Luc reporter 
assay. The solid black bar shows basal reporter activity in NOTCH1-expressing HEK293 cells. Data are 
means from quadriplicate measures of each coculture; error bars represent standard deviations (*P < 
0.05 determined by Student’s t test).
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MIB1 mutant forms reduced the activity of the 
reporter (Fig. 20 G) indicating that both human 
mutations disrupt Notch signalling.
Figure 21. MIB1-dimer analysis by FRET.
(A) For negative controls, HEK293T cells were co-transfected with empty pEYFP-C1 plus empty 
pECFP-C1, empty pEYFP-C1 plus pECFP-C1 encoding CFP-tagged WT MIB1, or pEYFP-C1 encoding 
YFP-tagged WT MIB1 plus pECFP-C1. For a positive control, HEK293T cells were co-transfected 
with pEYFP-C1 encoding YFP-tagged WT MIB1 and pECFP-C1 encoding CFP-tagged WT MIB1. 
HEK293 cells were co-transfected in pair-wise combinations with pEYFP-C1, WT MIB1 plus pECFP-C1 
encoding CFP-tagged p.Val943Phe or p.Arg530X. Images are shown before and after photobleaching 
of the acceptor within the indicated region. FRET efficiency was determined by the acceptor (YFP) 
photobleaching method and was measured only in the (acceptor) bleached area. Scale bar=20μm. 
(B) Quantification of FRET efficiency. Differences were significant when comparing the different MIB1 
combinations to all three negative controls. p<0.05.
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Mib1 regulates cardiac 
development and disease genes
After analysing the biochemical effects of 
the MIB1 mutations we wanted to study the 
effect that deletion of Mib1 in the myocardium 
has in ventricular development and maturation.
Analysis of chamber markers in E15.5 
Mib1flox;cTnT-cre mice revealed expansion 
of the compact myocardium markers Hey2 
(Koibuchi and Chin, 2007), Tbx20 (Singh et 
al., 2005) and n-Myc (Moens et al., 1993) 
to the trabeculae (Fig. 21 A) and reduced 
expression of the trabecular markers Anf (also 
known as Nppa) (Zeller et al., 1987), Bmp10 
(Chen et al., 2004) and Cx40 (also known as 
Gja5) (Van Kempen et al., 1996) (Fig. 22 A). 
We confirmed these observations by qPCR 
showing an increase of relative expression 
of the compact zone genes and a reduction 
of the trabecular genes (Fig. 22 B). Analysis 
of BrdU incorporation revealed increased 
proliferation of in between 10% and 15% of 
trabecular cardiomyocytes in the hearts of 
E15.5 Mib1flox;cTnT-cre embryos (Fig. 22 
C, D) suggesting increased cardiomyocyte 
proliferation as the cause of the enlarged, 
non-compacted trabeculae in these mutants. 
Interestingly there were no differences in 
proliferation in the compact zone of mutant 
ventricles. The altered gene expression 
at E15.5 suggests that maintenance of 
trabecular maturation and patterning is 
impaired in Mib1flox;cTnT-Cre mutant mice. All 
the markers mentioned above were normally 
expressed in E11.5 Mib1flox;cTnT-Cre mutant 
mice (Fig. 23 A-E). The same happened at 
postnatal day 3 (P3). At postnatal stages not 
only the expression of Hey2, Anf, Bmp10 and 
Cx40 became normalized again (Fig. 24 A-D), 
but also the proliferation rate is normalized as 
well at this stage (Fig. 24 E). Suggesting that 
LVNC is a developmental disease with a very 
specific time window. Compaction starts after 
the trabeculae have been formed at E11.5 and 
finishes before birth.
Coronary artery devel opment also seemed 
to be defective, as indicated by lost or 
reduced expression of Hey1, Hey3 and Efnb2 
(ephrinB2) in the vessels of the compact 
myocardium (Fig. 25 A, B, D). Whether the 
absence of proper coronary vessels in the 
compact myocardium is a consequence of 
the non-compaction of the myocardium or is 
causal to this phenotype is not yet clear and 
it would be a very interesting question to 
address.  
Expression of endocardial markers such 
as Nrg1 or Irx5 and myocardial markers such 
as Irx4, MyH7 and Nkx2.5 remains unaltered 
in the non-compacted hearts of Mib1flox;cTnT-
Cre mice (Fig. 25 C. E-H). These results 
suggest that the non-compaction phenotype 
is a chamber maturation defect that does not 
affect lineage identity.
Global gene expression a analysis of 
E14.5 Mib1flox;cTnT-Cre mutant ventricles by 
RNA sequencing (RNA-seq) identified altered 
expression of 315 genes (P ≤ 0.05); 132 
of these genes were up-regulated and 183 
were down-regulated (Complete data of the 
RNA-seq is supplied with the supplementary 
files). This experiment confirms the initial 
marker analysis; Tbx20 and Hey2 were up-
regulated, whereas Anf, Bmp10 and Cx40 
were down-regulated in the mutant ventricles. 
We also detected alterations in the expression 
of genes involved in the differentiation of 
cardiac endothelium and endocardium (Vwf, 
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Figure 22. Defective ventricular maturation and cardiac gene expression in E15.5  
Mib1flox;cTnT-Cre mice.
(A) In situ hybridization in E15.5 hearts showing that the compact myocardium markers Hey2, 
Tbx20 and n-Myc expand to the trabeculae, whereas the trabecular markers Anf, Bmp10 and Cx40 are 
downregulated in Mib1flox;cTnT-Cre mutant mice. Arrowheads indicate where the gene is expressed. 
Scale bar, 50 μm. (B) qPCR analysis of the markers shown in (A). Data are the means ± s.e.m. from 
four sets of independent WT and mutant samples relative to β-actin. WT expression was normalized 
to 1. (C) Trabeculae remain proliferative in Mib1flox;cTnT-Cre hearts, as shown by immunostaining of 
incorporated BrdU in WT and Mib1flox;cTnT-Cre hearts after a 1-h pulse at E15.5, with details of the left 
ventricle shown. Arrowheads indicate BrdU-positive nuclei. (D) The ratios of BrdU-positive to total nuclei 
reveal significantly elevated proliferation in the trabeculae of Mib1flox;cTnT-Cre hearts. n = 3 embryos per 
genotype. *P < 0.05 by Student’s t test. Ratios shown were calculated for both ventricles, and the images 
are from the left ventricles. Data are the means ± s.e.m.
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Figure 23. Compact zone and trabecular markers are normally expressed at E11.5. 
In situ hybridization (A) Hey2, (B) n-myc, (C) Anf, (D) Bmp10, (E) Cx40 in wild-type (WT) and 
Mib1flox;cTnT-Cre E11.5 hearts showing normal expression of trabecular and compact zone markers. 
All sections are transverse. None of the markers shows evident changes in overall expression levels or 
expression patterns. Note that the phenotype seen at later stages of development in Mib1flox;cTnT-Cre 
hearts is not apparent at E11.5. Scale bar=200μm. rv, right ventricle; lv, left ventricle.
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Hif1a, Epha4 and Irx1) and cardiomyocytes 
(Irx4, Myl2, Tnnt2, Myo3b and Bmp5). Genes 
involved in coronary vasculogenesis (Epas1, 
Adam19, Foxc1, Sema3a and Angpt1) were 
also down-regulated, reflecting the markedly 
reduced coronary vasculature of Mib1flox;cTnT-
Figure 24. Chamber gene expression and cell proliferation are normal in Mib1flox;cTnT-Cre 
postnatal hearts.
Transverse sections of postnatal-day-3 wild-type (WT) and Mib1flox;cTnT-Cre hearts. In situ hybridization 
of (A) Hey2, (B) Anf, (C) Bmp10 and (D) Cx40 show similar expression patterns in WT and mutants. (E) 
Cardiac cell proliferation measured by BrdU incorporation is also similar as shown by immunostaining 
of incorporated BrdU in WT and Mib1flox;cTnT-Cre hearts after a 1-h pulse at P3, with details of the left 
ventricle shown. The ratios of BrdU-positive to total nuclei reveal no statistical difference. n = 3 embryos 
per genotype. *P < 0.05 by Student’s t test. Ratios shown were calculated for both ventricles, and the 
images are from the left ventricles. Data are the means ± s.e.m. Scale bar=200μm. rv, right ventricle; lv, 
left ventricle; ra, right atrium; la, left atrium.
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Cre mutant mice (Fig. 26 A).
Gene Ontology classification showed that 
several genes deregulated in Mib1flox;cTnT-
cre ventricles encode cardiac developmental 
regulators and signalling pathways mediating 
cardiac hypertrophy (Fig. 26 B). The RNA-seq 
data confirmed our in situ hybridization analysis 
and demonstrated that Mib1 inactivation in 
the myocardium disrupts the differentiation 
Figure 25. The identity of chamber endocardium and myocardium is not altered in E15.5  
Mib1flox;cTnT-Cre mice.
Transverse sections of wild-type (WT) and Mib1flox;cTnT-Cre heart at E15.5. In situ hybridization of 
chamber endocardium, myocardium and coronary vessels markers; (A) Hey1, (B) Hey3, (C) Nrg1, (D) 
EphrinB2, (E) Irx5, (F) Irx4, (G) MyH7 and (H) Nkx2.5. None of the markers shows evident changes 
in overall expression levels. Arrowheads (insets A, B, C) mark the coronary vessels in the compact 
myocardium, which appear small in Mib1flox;cTnT-Cre hearts, consistent with the loss of Hey1, Hey3 and 
EphrinB2 expression. Scale bar=200μm. rv, right ventricle; lv, left ventricle. 
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and maturation of cardiomyocytes and the 
formation and development of the vascular 
coronary plexus (Fig. 26 B). This would in turn 
affect the process of ventricular maturation 
and compaction.
Deletion of Mib1 in the myocardium 
on Mib1flox;cTnT-Cre mice leads to LVNC 
cardiomyopathy by arresting the maturation 
and compaction of the trabeculae that maintain 
a proliferative status during foetal stages. 
Figure 26. Global expression analysis of E14.5 Mib1flox;cTnT-Cre hearts.
(A) List of selected dysregulated genes identified by RNA-seq and ordered by fold change from wild-
type, with red indicating up-regulated genes and green indicating down-regulated genes. Color codes 
indicate the biological functions of the genes. The column on the right lists the subset of dysregulated 
genes that are developmental genes related to cardiovascular disease. (B) Analysis of functional 
categories for the dysregulated genes in Mib1flox;cTnT-Cre hearts. B-H P value, Benjamini-Hochberg–
adjusted P value. The percentage changed indicates the percentage of genes involved in the listed 
biological functions that changed in comparison to WT. The total percentage changed is over 100% 
because a given gene can be involved in more than one biological function.
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The Mib1flox mouse is an 
excellent tool to study the role 
of the Notch ligands in cardiac 
development
The Notch pathway elements are widely 
expressed during heart development. Mib1, 
the E3 ubiquitin ligase responsible for the 
endocytosis of ligands and the activation of 
the pathway, is expressed ubiquitously in the 
embryo during development and in the heart, 
in particular in the two earliest differentiating 
tissues, the endocardium and myocardium. 
MIb1 regulates signalling of the Notch ligands 
Dll4 and Jag1 that are differentially expressed 
in the heart. Both ligands are expressed in 
the endocardium of the valvular regions, but 
in the chambers, Dll4 is expressed in the 
endocardium and Jag1 in the myocardium.
Notch1, the main receptor in the heart, is 
expressed throughout the whole endocardium 
(Timmerman et al., 2004) but the protein is only 
active in the endocardium of AVC, OFT and 
trabeculae suggesting that the endocardium is 
a key tissue for Notch signalling in the heart.
Targeted inactivation of Mib1 in the heart 
with different tissue-specific drivers allows us 
not only to study the role of Mib1 as a regulator 
of Notch signalling during heart development, 
but also in the case of the chambers, where the 
ligands are differentially expressed, to dissect 
their role (-s). Standard targeted inactivation 
of Mib1 produces phenotypes similar to those 
observed in Notch1 null mutants (Koo et al., 
2005a).
Mib1 deletion in the 
endocardium disrupts early heart 
development
The results observed using the Mib1flox;Tie2-
Cre mice indicate that Mib1 plays an important 
role during early heart development. Dll4 is 
the only ligand with endocardial expression 
at this stage, thus being a potential Mib1 
substrate, suggesting that the phenotype 
of Mib1 endocardial inactivation reflects an 
impairment of Dll4 signalling. At E9.5, the 
Mib1flox;Tie2-Cre mutant phenotype consists 
in a developmental delay and pericardial 
dilation. Molecularly, there is a marked 
reduction in Notch1 activity and the cardiac 
expression of the Notch target genes, Hey1, 
Hey2 and HeyL is diminished. Histologically, 
we observe that Mib1flox;Tie2-Cre mice fail to 
undergo cardiac looping, a severely reduced 
EMT, trabeculation is impaired and there is a 
reduction in cellular proliferation.
This phenotype results to be lethal at 
around E11. At E9.5 what we observe is that 
Mib1flox;Tie2-Cre mice fail to undergo cardiac 
looping and that EMT and trabeculation are 
impaired. These phenotypes prove the crucial 
role of Mib1 in the endocardium during these 
important events that take place during early 
heart development. It also identifies Dll4 
as the ligand responsible Notch activation 
during early heart development. Cardiac 
phenotypes observed in standard Notch1 and 
RBPJK knock-outs or endocardial-vascular 
conditional Notch1 mutants (Timmerman et 
al., 2004, Grego-Bessa et al., 2007) are similar 
to the ones observed upon Mib1 endocardial-
vascular deletion, suggesting that there 
is a MIb1-Dll4-Notch1 signalling cascade 
necessary for early heart development. 
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Abrogation of Mib1-Dll4-Notch1 signalling 
disrupts trabeculation (Fig. 27 B, C) and the 
formation of the endocardial cushions by EMT; 
it leads to a poor heart function that can be 
observed by the dilation of the pericardium in 
the mutant embryo at E9.5. This Mib1-Notch 
phenotype is not caused by any of the other 
Notch E3 ubiquitin ligases that are dispensable 
for development (Vollrath et al., 2001, Ruan 
et al., 2001, Koo et al., 2007), suggesting 
that there are no functional redundancies 
of Mib1 with Mib2, Neurl1 or Neurl2 during 
development.
Thus, we suggest that during early heart 
development, Notch1 activation is driven by 
Dll4. Our data also identify the endocardium 
as a key signalling tissue during early heart 
Trabecule
Endocardium
Myocardium
Compact Zone
Myocardium
Dll4
N1ICD
Nrg1
(proliferation)
Mib1
Endocardium Myocardium
Trabecule
Dll4
N1ICD
Nrg1
Bmp10
(proliferation)
X
X
Mib1X
X(differentiation)
(differentiation
X
rv lv
a
oft
avc
E9.5
B
C
A
X
Endocardium
Myocardium
Cardiac
Jelly
Dll4
Mib1
N1ICD
Myocardium
Endocardium
Dll4
Cardiac
Jelly
Mib1
N1ICD
Snail1
WT Mib1flox;Tie2-CreC
B WT Mib1flox;Tie2-Cre
X
X
X
Bmp10
Snail1
Cdh5 Cdh5
X
Compact Zone
Myocardium
101
DISCUSSION
development. Signals emanating from the 
endocardium (ie: Nrg1, TGFb2) are necessary 
for the crucial events that take place during this 
time, such as trabeculation or valvulogenesis. 
In the case of the trabeculae, the myocardium 
responds to these signals (Fig. 27). Our results 
leave an open question of what is the temporal 
specificity of Jag1, the ligand expressed in the 
myocardium that we think is involved in the 
LVNC phenotype observed. 
Mib1 deletion causes 
dysmorphic OFT valves
The early lethality of Notch mutant mice 
has not allowed us until now to study the 
development of the heart beyond mid-
gestation. At E9.5, valvulogenesis and 
trabeculation are already underway but the 
morphogenetic processes that transform an 
embryonic heart into a mature adult heart 
have not yet started. Endocardial cushions 
have to form the valves and the trabeculae 
will contribute to the compacted ventricular 
wall. Deletion of Mib1 with Nkx2.5-Cre has 
allowed us to study the role of Notch signalling 
pathway in valve development beyond EMT 
and trabeculation.
Nkx2.5 is expressed in the endocardium 
similarly to Tie2, but it is not expressed in the 
vascular endothelium. Although we have not 
performed a precise time-course of activation 
of these two Cre drivers, bot have been 
described to be active from E7.5 onwards 
(Kisanuki et al., 2001b, Stanley et al., 2002). 
The observation that Tie2-Cre-mediated 
Mib1 inactivation causes lethality at E10.5 
and Nkx2.5-Cre prior to birth, suggests that 
Mib1 function in the vasculature is crucial 
for embryonic viability. These differences in 
viability have allowed us to study the role of 
Mib1-Notch signalling in valve morphogenesis.
Standard inactivation of Dll4 causes lethality 
in a haplo-insuficient manner and produces a 
severe vascular phenotype (Krebs et al., 2004, 
Duarte et al., 2004). MIb1, Dll4 (D’Amato, 
unpublished), and Notch1 inactivation in the 
endocardium is recessive lethal, indicating 
the importance of using endocardial-specific 
drivers to study the role of Notch in the heart.
Mib1flox;Nkx2.5-Cre mice show dysmorphic 
OFT valves due to increased cellular 
proliferation in the valve mesenchyme. After 
EMT, the large endocardial cushions undergo 
a morphogenetic process leading to the 
mature functional valves. Program cell death 
or apoptosis in the mesenchyme of the valve 
primordial in involved in the morphogenesis of 
Figure 27. Proposed mechanism of Notch regulation of early heart development.
(A) Schematic wild-type (WT) heart at E9.5. (B) In WT embryos, ubiquitylation of Dll4 allows Notch 
activation in the endocardium of the valves. N1ICD is required for the repression of Cdh5. This will 
allow the endocardial cells to undergo EMT, invade the cardiac jelly and form the valve primordia. In 
Mib1flox;Tie2-Cre embryos the absence of Mib1 inhibits the activation of N1ICD that is not able to supress 
Cdh5, thus only some endoccardial cells undergo EMT and invade the cardiac jelly. There is no formation 
of the valve primordia. (C) In WT embryos ubiquitylation of Dll4 allows Notch activation at the base of 
the trabecules. N1ICD activation is required for the expression of Nrg1 and Bmp10 that are required for 
the differentiation and maturation of the ventricles. In Mib1flox;Tie2-Cre embryos the absence of Mib1 
inhibits the activation of N1ICD by Dll4 so that Bmp10 and Nrg1 are not expressed and the ventricle fails 
to develop.
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the valves (Hinton and Yutzey, 2011). On this 
context, Notch has been described as being 
required for the migration of the neural crest-
derived mesenchyme that is cruciallly involved 
in the apoptosis of the cushion mesenchyme 
(Jain et al., 2011). Our findings indicating the 
presence of neural crest-derived mesenchyme 
and the observation of normal apoptosis in the 
cushions of Mib1flox;Nkx2.5-Cre mice, rules out 
apoptosis as a mechanism responsible for the 
enlarged leaflets observed in these mutants.
Our data show that Notch signalling 
abrogation in the endocardium of the leaflets 
produces an up-regulation of Bmp6 and a 
down-regulation of its negative regulator 
Figure 28. Proposed mechanism of Notch pathway function in OFT valve leaflet 
morphogenesis and maturation.
(A) In wild-type (WT) embryos, ubiquitination of either Jag1 or Delta4 allows Notch activation in the 
endocardium of the valves. N1ICD is required for the expression of a still unknown non-cell autonomous 
regulator of BMP signalling in the mesenchyme of the leaflet. This will negatively regulate BMP and 
cellular proliferation will stop so that the leaflet can undergo the morphogenesis process required for 
valve maturation. (B) In Mib1flox;Nkx2.5-Cre valves, Notch1 activity is impaired so the unknown regulator 
of BMP might not be expressed producing a deregulation of BMP and an increased cellular proliferation 
in the mesenchyme of the maturing valve that will form large leaflets resulting in dysmorphic OFT valves.
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Smad6. Not only the expression of BMP 
genes is up-regulated, but also the activation 
of the pathway is up-regulated, as indicates 
the increased expression of phospho-Smad 
1/5/8 proteins in the mesenchyme of the 
OFT leaflets. Bmp6; Bmp7 double knockout 
mice have hypoplastic OFT cushions (Kim 
et al., 2001). Although both BMP proteins 
appear to be required for the development 
of the cushions, our results suggest that 
Bmp6 regulates the proliferation of cushion 
mesenchyme. Thus, we suggest that the 
enlarged leaflets are caused by increased 
proliferation of the mesenchymal cells due to 
the up-regulated BMP. The mutant leaflets are 
so large that they cannot align at the same 
level in the valve, thus being the likely cause 
of valve dysmorphology and incompetence.  
Our results suggest that endocardial Notch 
regulates BMP signalling and mesenchymal 
cell proliferation in a non-cell autonomous 
fashion (Fig 28 A). In the endocardium, Notch 
would regulate the expression of a diffusible 
molecule that signals to the mesenchyme 
where it negatively regulates BMP and cellular 
proliferation. In the Mib1flox;Nkx2.5-Cre mutant 
(Fig. 28 B), devoid of Notch activation in 
the valvulogenic territory, there would be no 
expression of this diffusible molecule and thus 
BMP and proliferation would be dysregulated, 
leading to a dysmorphic OFT valve.  The 
perinatal lethality of Mib1flox;Nkx2.5-Cre mice 
is likely due to the valve dysmorphology that 
severely disrupts cardiac function and causes 
death at a very demanding time point in terms 
of cardiac function: birth.
Jagged1 and Dll4 are both expressed 
in the OFT, thus the deletion of Mib1 does 
not allow us to dissect the specific-role 
of these ligands in valve morphogenesis. 
Nevertheless, the severe phenotype of Mib1 
strongly suggests an important role for these 
ligands in valve maturation. The similarities of 
the phenotypes observed in Mib1flox;Nkx2.5-
Cre and Mib1flox;Isl1-Cre mice suggest that 
the phenotypes are heart specific. Islet1 
derivatives in the heart are both neural crest 
and second heart filed origin (Engleka et 
al., 2012) but Nkx2.5 is only expressed in 
the heart. The regulation of mesenchyme 
proliferation by Notch from the endocardium 
during the maturation of the valves occurs 
after the migration of the other lineages in 
the heart. This suggests that they are two 
temporally separated processes, first EMT and 
migration of neural crest and then maturation 
and sculption of the leaflets. 
Valve dysmorphology, either AV or OFT 
valves, is one the most common valve CHD 
and it is one of the leading causes in adult 
heart disease (Goldbarg et al., 2007). Notch 
has been demonstrated to be crucial not only 
for early valve development (Timmerman et 
al., 2004, Luna-Zurita et al., 2010) but also 
to have an impact on adult valve disease 
(Garg et al., 2005, Nus et al., 2011). This work 
reveals the importance of Mib1 (and in s.l. of 
Notch) in valve development and its potential 
implication in human valve disease.
MIB1 mutations cause LVNC
The results obtained with the Mib1flox;cTnT-
Cre mice identify NOTCH as the first signalling 
pathway to our knowledge whose dysfunction 
has a causal role in LVNC. Until this moment 
the genes related to this cardiomyopathy were 
heterogeneous, mutations in structural genes 
of the cardiac fibers, mitochondrial genes or 
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in G4.5 that is located in the X chromosome 
have been shown to cause LVNC (Oechslin 
and Jenni, 2011). We think that this research 
opens a new avenue into our understanding 
of this cardiomyopathy, especially from the 
mechanistic point of view. 
Sequencing of the MIB1 coding exons 
in a cohort of 100 patients with LVNC (48% 
of which were familial cases) identified two 
germline mutations (V943F and R530X) in 
two probands. The two mutant families do not 
present mutations in the other genes that have 
already been associated with LVNC. These 
MIB1 mutations were associated with LVNC 
in an autosomal-dominant fashion. Image 
analysis of the hearts of the fathers of the two 
probands as well as those of family members 
with inherited MIB1 mutations showed the 
presence of prominent trabeculations in both 
ventricles, and most of these individuals 
also showed reduced cardiac performance. 
Analysis of peripheral blood from these 
patients revealed low N1ICD and target-
gene expression. In the two families the 
mutations segregated perfectly with the LVNC 
phenotype.
Additional evidence demonstrated that the 
V943F and R530X MIB1 mutations disrupt 
Notch signalling: (I) microinjection of the 
corresponding MIB1 mutant mRNAs into 
zebrafish embryos produces an embryonic 
and cardiac Notch-like phenotype; and (II) the 
activity of the Notch-RBP reporter 10xCBF1-
Luc is attenuated in vivo and in vitro as a result 
of expression of either of the MIB1 mutant 
mRNAs
Taking together all these data demonstrates 
that the two MIB1 mutations affect NOTCH 
signalling both in vivo and in vitro but more 
importantly this affection of the pathway is 
what causes the disease. 
Our findings indicate that MIB1 functions 
as a homodimer. In silico modelling suggests 
that WT MIB1 monomers form a head-to-tail 
homodimer that interacts with JAG1 through 
the Herc2 domain. Moreover, FRET signal 
measurements and co-immunoprecipitation 
studies showed that WT MIB1 monomers 
dimerize and that dimers are also formed 
between WT and mutant MIB1 monomers or 
between mutant monomers.
We were unable to detect expression of 
the predicted truncated protein produced 
by the R530X mutation in blood samples of 
patients with LVNC. qPCR and sequencing 
analyses of PCR products generated from the 
lymphocytes of these patients indicated that 
expression of the mutant mRNA harbouring 
the R530X mutation is almost completely 
abolished, probably by NMD. We suggest 
that in the settings of transfected HEK293 
cells or microinjected zebrafish embryos, 
the R530X mutant protein expressed from a 
cDNA construct and not subject to NMD has 
a dominant-negative effect on MIB1 function 
through heterodimerization with the WT MIB1 
protein. In contrast, the LVNC phenotype in 
patients with the R530X mutation would result 
from MIB1 haploinsufficiency. Expression 
of the mutant mRNA encoded by the V943F 
mutation was not affected in the lymphocytes 
of patients with LVNC and thus may give rise 
to an abnormal MIB1 monomer that is able 
to interact with a WT monomer, disrupting 
the function of the MIB1 heterodimer in a 
dominant-negative manner. This dominant-
negative effect has been described for the 
zebrafish mutant mib1ta52b, which behaves 
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similarly in ubiquitylation assays and harbours 
a missense mutation (M989R) in the C-terminal 
ring finger of mib1 (Zhang et al., 2007a), which 
is very close to the location of the MIB1 V943F 
mutation.
Thus, we propose that both mutations 
result in loss of MIB1 WT function. In the 
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Figure 29. Proposed mechanism of Notch pathway function in trabecular maturation and 
compaction.
(A) In wild-type (WT) embryos, ubiquitylation of Jag1 by Mib1 in the myocardium allows Notch1 
activation in the endocardium at the base of the developing trabeculae (red-filled cells). N1ICD is required 
to sustain trabecular patterning, maturation and compaction. The compact myocardium (positive for Hey2, 
Tbx20 and n-Myc) proliferates actively, unlike the trabecular myocardium (positive for Anf, Bmp10 and 
Cx40). Notch-dependent chamber maturation leads to compacted ventricular myocardium in the adult 
mouse. (B) In Mib1flox;cTnT-Cre embryos, Notch1 activity is impaired and compact myocardium markers 
(Hey2, Tbx20 and n-Myc) are consequently expanded to the trabeculae, which remain abnormally 
proliferative. The resulting disruption of trabecular patterning, maturation and compaction manifests as 
LVNC.
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case of R530X, this would be due to haplo-
insufficiency caused by insufficient synthesis 
of WT MIB1 protein; in the case of V943F, 
this would be due to a dominant-negative 
effect of the mutant protein, titrating down the 
amount of functional WT MIB1 dimers through 
heterotypic or homotypic interactions. In both 
cases, loss of MIB1 function leads to disease 
inherited in an autosomal-dominant fashion.
Endocardial-vascular inactivation of 
Mib1 showed that Notch signalling is 
essential for the first events of ventricular 
chamber development. Similarly systemic or 
endocardial-specific inactivation of mouse 
Notch1 or Rbpj disrupts trabeculation, leading 
to the formation of an anomalous ‘spongy’ 
myocardial wall. During this early stage of 
trabeculation, the ligand Dll4 is the main Notch 
activator in the endocardium (Grego-Bessa et 
al., 2007). We found that inactivation of Mib1 
in the myocardium gives rise to a dilated heart 
with enlarged ventricular trabeculae and a 
thin compact myocardium. Echocardiographic 
and CMRI analyses indicated that this 
phenotype persists in the adult heart, which 
had a reduced ejection fraction and a non-
compaction index of 2.0. These features are 
all strongly reminiscent of LVNC, establishing 
Mib1flox;cTnT-Cre mice as the first animal 
model of LVNC, to our knowledge. Although 
Mib1flox;Nkx2.5-Cre show the same phenotype 
observed in the LVNC model their perinatal 
lethality caused by the valve maturation arrest 
disqualifies these mice as a model for LVNC. 
We propose that myocardial Mib1 
activity enables Jag1-dependent activation 
of Notch1 in the endocardium, triggering 
downstream signalling events that sustain 
normal trabecular patterning, maturation and 
myocardial compaction processes occurring 
in the mouse embryo, well after mid-gestation 
(>E11.5; Fig. 29). This hypothesis is consistent 
with the RNA-seq data showing that a set 
of differentiation genes for endothelium, 
endocardium and trabecular cardiomyocytes 
was down-regulated in Mib1flox;cTnT-cre 
mutant embryos. The expansion of compact 
zone markers to the trabeculae of E15.5 
Mib1flox; cTnT-cre mutant mice further suggests 
that trabecular patterning and maturation 
is impaired. In addition, the disruption of 
coronary vessel markers in Mib1flox;cTnT-Cre 
mutants indicates correct compaction of the 
ventricular wall is required for the coronary 
plexus formation. Notch signalling inactivation 
indirectly impairs coronary vessel formation.
The expression of the maturation and 
differentiation markers that are disrupted at 
E15.5 is unaffected at E11.5. The same occurs 
with the proliferation. At P3, when analysed 
in newborn mice markers expression and 
cellular proliferation are normal, suggesting 
that the MIb1-dependent processes leading 
to myocardial compaction are over. These 
observations suggest that the NOTCH-related 
LVNC has a developmental basis and that 
the process of compaction happens within a 
precise time window. 
The abrogation of myocardial-endocardial 
Mib1-Jag1-Notch1 is crucial for the ventricular 
maturation. It is also required for compaction 
of the ventricular walls and for coronary plexus 
formation. These findings suggest that Jag1 is 
the ligand responsible for chamber maturation 
in the chamber, while Dll4 would be required 
for early chamber development. 
NOTCH signalling alterations are involved 
in a range of human congenital heart disease 
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with autosomal-dominant inheritance, 
suggesting a high sensitivity of normal heart 
development to NOTCH dosage (High and 
Epstein, 2008, MacGrogan et al., 2010, 
Gridley, 2010). The complexity of NOTCH 
function in the human heart becomes evident 
from the specificity of the disease phenotypes 
associated with NOTCH alteration. Our 
current data establish the causal role of 
NOTCH dysregulation in LVNC, a congenital 
cardiomyopathy that results from a 
developmental arrest in ventricular maturation 
and myocardial compaction. These findings 
have the potential to improve diagnosis and 
risk stratification, allowing timely intervention 
in LVNC-associated complications (Sarma 
et al., 2010). In addition, as other NOTCH 
pathway elements may be involved in LVNC, 
our findings may help identify new diagnostic 
or therapeutic disease targets.
Mib1 is crucial for heart 
development
The different phenotypes observed upon 
deletion of Mib1 in the endocardium and in 
the myocardium indicate that consecutive 
endocardial-myocardial Notch signalling is 
crucial for the progression of cardiomyocyte 
differentiation in the ventricles and cardiac 
valve cushion morphogenesis. The key role 
of Notch signalling in the heart is reflected 
in the consecutive implication of the ligands 
Dll4 and Jag1, differentially expressed in the 
heart. In the chambers, at an early stage of 
ventricular development, Dll4 is the ligand 
activating Notch1 (Mib1- mediating) within 
the endocardium, while myocardial Jagged1 
does not seems to be functionally relevant, 
as there is not an early mutant phenotype 
for Mib1flox;cTnT-Cre mutants. One intriguing 
observation is that at this early stage of 
chamber development (E9.0-E10.5), chamber 
endocardium is only in close apposition with 
the myocardium at the base of the developing 
trabeculae. As development proceeds, 
Jagged1 expressed in the myocardium would 
be able to activate Notch1 in the endocardium 
because ventricular growth has lead to a 
close apposition of trabecular endocardium 
and myocardium. At this developmental stage 
(E13.5) is when Mib1flox;cTnT-Cre mutants 
begin to show a severe foetal and later adult 
LVNC phenotype. Our results could be further 
elaborated by the recently observed expression 
of a modulator of the Notch receptor, Manic 
fringe (G. D’Amato, unpublished data) that 
selects spatio-temporally the signaling 
specificity of the ligands. In conclusion, 
Notch ligands play different roles during 
ventricular chamber development. Dll4 is 
more important during early development, 
while Jag1 in the later but crucial processes 
of chamber maturation and compaction. We 
suggest that during ventricular development 
there is sequential activation of the ligands 
(G. D’Amato, unpublished data). Whether 
this phenomenon is only spatially regulated 
or there is also a time component remains 
undetermined.
In the valves, although Dll4 is also required 
for EMT and the early events of valvulogenesis, 
there is no a spatial difference between Dll4 
and Jag1 endocardial expression. This makes 
impossible to dissect with Mib1 the influence 
of the two ligands in valve maturation and 
morphogenesis. It becomes clear that 
Notch is crucial not only for triggering valve 
development by EMT, but also for the 
maturation and homeostasis of the structure. 
Tissue-specific Mib1 deletion disrupts Notch 
signaling in the endocardium. Endocardial 
Notch activity regulates cardiac valve and 
chamber development and maturation. In 
these processes, endocardial Notch acts in 
a non-cell autonomous manner to regulate 
valve morphogenesis and cardiac chamber 
maturation.
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1. The Notch ligands are differentially expressed in the heart. In the ventricles Dll4 is expressed 
in the endocardium, and Jagged1 in the myocardium. In the valves, both ligands are expressed in 
the endocardium. Genetic manipulation of Mib1 is an excellent approach to genetically dissect the 
role of the ligands Dll4 and Jagged1 in heart development, as its inactivation allows us to study 
the full effect of Notch ligands signalling abrogation.
2. Notch activation in the endocardium orchestrates the non-cell autonomous effects in the 
myocardium essential for trabecular development and myocardial compaction, and thus is crucial 
for heart development.  
3. Genetic inactivation of Mib1 in the endocardium-endothelium disrupts heart development. 
Trabeculae and endocardial cushions are not formed. Delta4 is the ligand responsible for this 
early Notch phenotype.
4. Genetic inactivation of Mib1 in the endocardium and in the myocardium blocks OFT valve 
maturation producing dysmorphic valve leaflets. We have been unable of fully dissecting which 
of the ligands is responsible for this phenotype, although our data suggest an early role only 
for Dll4 in endocardial EMT but we cannot discard that both Dll4 and Jag1 participate in valve 
morphogenesis.
5. During valve morphogenesis, Notch regulates BMP signalling in a non-cell autonomous 
manner modulating mesenchymal cellular proliferation in the leaflets. The deregulation of BMP 
signalling is responsible for the increased size of the OFT valve leaflets of Mib1flox;Nkx2.5-Cre 
mice. 
6. Genetic inactivation of Mib1 in the myocardium causes a severe ventricular phenotype 
that resembles the human LVNC cardiomyopathy. MIb1 myocardial inactivation impairs the 
maturation of the myocardium, and the trabeculae express compact myocardium markers and 
remain proliferative. This phenotype is likely caused by the abrogation of Jag1 signalling from the 
myocardium. 
7. Mutations in human MIB1 cause LVNC cardiomyopathy, the third most important 
cardiomyopathy. LVNC MIB1 pedigrees show a perfect correlation of phenotype and genotype 
and the mutations are inherited in an autosomal dominant manner. 
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8. V943F MIB1 mutation has a dominant negative effect on the WT protein causing the 
cardiomyopathy; on the other hand the R530X mutation produces the cardiomyopathy by haplo-
insufiency of the MIB1 protein. 
9. NOTCH-dependent LVNC has a developmental basis making NOTCH a new diagnostic 
tool for the cardiomyopathy. 
113
CONCLUSIONS / CONCLUSIONES
 
1. Los ligandos de Notch se expresan diferencialmente en el corazón. En los ventrículos 
Dll4 se expresa en el endocardio y Jag1 en el endocardio. En las válvulas ambos se expresan en 
el endocarido. La manipulación genética de Mib1 es una abordaje excelente para diseccionar el 
papel de los ligandos Dll4 y Jag1 durante el desarrollo cardiaco. 
2. La activación de Notch en el endocardio tiene efectos no autónomo celulares en el 
micoardio que son esenciales para el desarrollo trabecular y la compactación del ventrículo, y 
por ello son cruciales para el desarrollo del corazón. 
3. La inactivación genética de Mib1 en el endocardio y el endotelio interrumpe el desarrollo 
del corazón. Las trabéculas y los colchones del endocardio no se forman. Dll4 es el ligando 
responsable de este fenotipo temprano de Notch.
4. La inactivación genética de Mib1 en el endocardio y en el miocardio bloquea la maduración 
de las válvulas del OFT produciendo valvas dismórficas. No hemos podido determinar que ligando 
es responsable de este fenotipo, aunque nuestros datos sugieren un papel temprano de Dll4 en 
la EMT del endocardio, no podemos descartar que Dll4 y Jag1 participen conjuntamente en la 
morfogénesis de las válvulas.
5. Durante la morfogénesis de las válvulas, Notch regula la señalización por BMP de una 
manera no autónoma celular, modulando la proliferación celular en las valvas. La desregulación 
de la señalización por BMP es responsable del incremento de tamaño de las valvas en las 
válvulas del OFT en los ratones Mib1flox;Nkx2.5-Cre.
6. La eliminación de Mib1 en el miocardio cause un severo fenotipo ventricular similar a la 
cardiomiopatía humana LVNC. La inactivación de Mib1 en el miocardio impide la maduración del 
miocardio, las trabéculas expresan marcadores de miocardio compacto y mantienen el estado 
proliferativo. Este fenotipo parece ser causado por la eliminación de la señalización dependiente 
de Jag1 desde el miocardio. 
7. Mutaciones en MIB1 humano causan la cardiomiopatía LVNC., que es la tercera 
cardiomiopatía más importante. Los pedigríes de LVNC producidos por mutaciones en MIB1 
presentan una correlación perfecta entre fenotipo y genotipo, y las mutaciones en MIB1 se 
114
Regulating NOTCH ligands
The role of Mind bomb1 during cardiac development and disease
heredan de manera autosómica dominante. 
8. En caso de la mutación V943F la proteína MIB1 mutante tiene un efecto dominante 
negativo causante de la enfermedad, mientras que en el caso de la R530X la cardiomiopatía se 
produce por haplo insuficiencia de MIB1. 
9. La LVNC dependiente de NOTCH tiene una base de desarrollo. Esto transforma a NOTCH 
en una nueva herramienta de diagnostico para la cardiomiopatía. 
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